{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:24:29Z","timestamp":1792621469178,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003177.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000}}],"reference-count":566,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003177.pub3","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T01:08:40Z","timestamp":1531962520000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease"],"prefix":"10.1002","author":[{"given":"Asmaa S","family":"Abdelhamid","sequence":"first","affiliation":[{"name":"University of East Anglia; Norwich Medical School; Norwich Research Park Norwich Norfolk UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey J","family":"Brown","sequence":"additional","affiliation":[{"name":"University of East Anglia; Norwich Medical School; Norwich Research Park Norwich Norfolk UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julii S","family":"Brainard","sequence":"additional","affiliation":[{"name":"University of East Anglia; Norwich Medical School; Norwich Research Park Norwich Norfolk UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Biswas","sequence":"additional","affiliation":[{"name":"University of East Anglia; MED\/HSC; Norwich Research Park Norwich UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle C","family":"Thorpe","sequence":"additional","affiliation":[{"name":"University of East Anglia; School of Health Sciences; Earlham Road Norwich UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J","family":"Moore","sequence":"additional","affiliation":[{"name":"Durham University; Wolfson Research Institute; Durham UK DH1 3LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine HO","family":"Deane","sequence":"additional","affiliation":[{"name":"University of East Anglia; School of Health Sciences; Earlham Road Norwich UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fai K","family":"AlAbdulghafoor","sequence":"additional","affiliation":[{"name":"University of East Anglia; Norwich Medical School; Norwich Research Park Norwich Norfolk UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn D","family":"Summerbell","sequence":"additional","affiliation":[{"name":"Durham University; Department of Sport and Exercise Science; 42 Old Elvet Durham UK DH13HN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V","family":"Worthington","sequence":"additional","affiliation":[{"name":"Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; Cochrane Oral Health; JR Moore Building Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujian","family":"Song","sequence":"additional","affiliation":[{"name":"University of East Anglia; Norwich Medical School; Norwich Research Park Norwich Norfolk UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Hooper","sequence":"additional","affiliation":[{"name":"University of East Anglia; Norwich Medical School; Norwich Research Park Norwich Norfolk UK NR4 7TJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"issue":"17","key":"10.1002\/14651858.CD003177.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"issue":"14","key":"10.1002\/14651858.CD003177.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2014.07.956","article-title":"Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress","volume":"64","author":"Nigam","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1016\/j.cjca.2013.07.658","article-title":"Multicentre trial of fish oil for the reduction of atrial fibrillation recurrence, inflammation and oxidative stress: the atrial fibrillation fish oil research study","volume":"1","author":"Nigam","year":"2013","journal-title":"Canadian Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4070\/kcj.2016.46.4.481","article-title":"Effect of n-3 polyunsaturated fatty acids on regression of coronary atherosclerosis in statin treated patients undergoing percutaneous coronary intervention","volume":"46","author":"Ahn","year":"2016","journal-title":"Korean Circulation Journal"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"e81519","DOI":"10.1371\/journal.pone.0081519","article-title":"Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial","volume":"8","author":"Brouwer","year":"2013","journal-title":"PLOS ONE"},{"issue":"13","key":"10.1002\/14651858.CD003177.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehr499","article-title":"Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction","volume":"33","author":"Eussen","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.jalz.2011.05.1432","article-title":"Effects of n-3 fatty acids on cognitive decline: a randomized double-blind, placebo-controlled trial in stable myocardial infarction patients","volume":"1","author":"Geleijnse","year":"2011","journal-title":"Alzheimer's & Dementia"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jalz.2011.06.002","article-title":"Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients","volume":"8","author":"Geleijnse","year":"2012","journal-title":"Alzheimer's & Dementia"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ahj.2009.12.033","article-title":"Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial","volume":"159","author":"Geleijnse","year":"2010","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1365-2605.2012.01255.x","article-title":"No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial","volume":"35","author":"Giltay","year":"2012","journal-title":"International Journal of Andrology"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3945\/ajcn.111.018259","article-title":"Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction","volume":"94","author":"Giltay","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0012|cit12","first-page":"ii64","article-title":"Effects of N-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega Trial","volume":"27","author":"Hoogeveen","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/2047487313494295","article-title":"No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial","volume":"21","author":"Hoogeveen","year":"2014","journal-title":"European Journal of Preventive Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD003177.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2215\/CJN.10441013","article-title":"Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial","volume":"9","author":"Hoogeveen","year":"2014","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2337\/dc11-0896","article-title":"N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in post myocardial infarction patients with diabetes","volume":"34","author":"Kromhout","year":"2011","journal-title":"Diabetes Care"},{"issue":"18","key":"10.1002\/14651858.CD003177.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"N-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"e81519","DOI":"10.1371\/journal.pone.0081519","article-title":"Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial","volume":"8","author":"Brouwer","year":"2013","journal-title":"PLOS ONE"},{"issue":"13","key":"10.1002\/14651858.CD003177.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehr499","article-title":"Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction","volume":"33","author":"Eussen","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.jalz.2011.05.1432","article-title":"Effects of n-3 fatty acids on cognitive decline: A randomized double-blind, placebo-controlled trial in stable myocardial infarction patients","volume":"1","author":"Geleijnse","year":"2011","journal-title":"Alzheimer's & Dementia"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jalz.2011.06.002","article-title":"Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients","volume":"8","author":"Geleijnse","year":"2012","journal-title":"Alzheimer's & Dementia"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ahj.2009.12.033","article-title":"Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial","volume":"159","author":"Geleijnse","year":"2010","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1365-2605.2012.01255.x","article-title":"No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial","volume":"35","author":"Giltay","year":"2012","journal-title":"International Journal of Andrology"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3945\/ajcn.111.018259","article-title":"Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction","volume":"94","author":"Giltay","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0024|cit24","first-page":"ii64","article-title":"Effects of N-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega Trial","volume":"27","author":"Hoogeveen","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/2047487313494295","article-title":"No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial","volume":"21","author":"Hoogeveen","year":"2014","journal-title":"European Journal of Preventive Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD003177.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2215\/CJN.10441013","article-title":"Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial","volume":"9","author":"Hoogeveen","year":"2014","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2337\/dc11-0896","article-title":"N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in post myocardial infarction patients with diabetes","volume":"34","author":"Kromhout","year":"2011","journal-title":"Diabetes Care"},{"issue":"18","key":"10.1002\/14651858.CD003177.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"N-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD003177.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"309","author":"Age-Related Eye Disease Study 2(AREDS2) Research Group","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","article-title":"Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jamaophthalmol.2013.4412","article-title":"Lutein\/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4","volume":"131","author":"Chew","year":"2013","journal-title":"JAMA Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ophtha.2013.12.035","article-title":"Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5","volume":"121","author":"Huynh","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jamainternmed.2014.328","article-title":"Effect of long-chain omega-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"174","author":"Bonds","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0036|cit35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamaophthalmol.2014.2009","article-title":"In reply: Making sense of the evidence from the age-related eye disease study 2 randomized clinical trial","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0035|cit36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jama.2015.9677","article-title":"Effect of omega-3 fatty acids, lutein\/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial","volume":"314","author":"Chew","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/07853890600852880","article-title":"Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention","volume":"38","author":"Baldassarre","year":"2006","journal-title":"Annals of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp.52.1.18","article-title":"A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis","volume":"52","author":"Bates","year":"1989","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archopht.122.9.1297","article-title":"Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment","volume":"122","author":"Berson","year":"2004","journal-title":"Archives of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/archopht.122.9.1306","article-title":"Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses","volume":"122","author":"Berson","year":"2004","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11745-001-0661-4","article-title":"A long-term seal- and cod-liver-oil supplementation in hypercholesterolemic subjects","volume":"36","author":"Brox","year":"2001","journal-title":"Lipids"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","article-title":"Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial","volume":"62","author":"Argo","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Caldwell SH Argo CK Henry TD Lackner C Pramoonjago P Weltman AL Dissociated histological and metabolic effects of omega-3 (3000 mg\/d) versus placebo with both exercise and diet in a double-blind randomized controlled trial of NASH Journal of Hepatology 2011 S8","DOI":"10.1016\/S0168-8278(11)60019-6"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0046|cit44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000419300","article-title":"Fatty fish and heart disease: a randomized controlled trial","volume":"66","author":"Burr","year":"1991","journal-title":"World Review of Nutrition and Dietetics"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0047|cit45","first-page":"1451","article-title":"Fish and the heart","volume":"ii","author":"Burr","year":"1989","journal-title":"Lancet"},{"issue":"8666","key":"10.1002\/14651858.CD003177.pub3-BIB0044|cit46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","article-title":"Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)","volume":"2","author":"Burr","year":"1989","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0045|cit47","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/oxfordjournals.eurheartj.a059528","article-title":"Diet and reinfarction trial (DART): design, recruitment, and compliance","volume":"10","author":"Burr","year":"1989","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/oxfordjournals.eurheartj.a060141","article-title":"Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART)","volume":"13","author":"Burr","year":"1992","journal-title":"European Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/oxfordjournals.eurheartj.a060645","article-title":"Diet and reinfarction","volume":"15","author":"Burr","year":"1994","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-277X.1991.tb00074.x","article-title":"Factors influencing compliance with dietary advice: the Diet and Reinfarction Trial (DART)","volume":"4","author":"Fehily","year":"1991","journal-title":"Journal of Human Nutrition and Dietetics"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1111\/j.1365-277X.1989.tb00026.x","article-title":"The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART)","volume":"2","author":"Fehily","year":"1989","journal-title":"Journal of Human Nutrition & Dietetics"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/sj.ejcn.1601342","article-title":"The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction Trial (DART)","volume":"56","author":"Ness","year":"2002","journal-title":"European Journal of Clinical Nutrition"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.jhh.1000913","article-title":"The long-term effect of advice to eat more fish on blood pressure in men with coronary disease: results from the diet and reinfarction trial","volume":"13","author":"Ness","year":"1999","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0056|cit54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S0029665107005241","article-title":"Secondary prevention of CHD in UK men: the diet and reinfarction trial and its sequel","volume":"66","author":"Burr","year":"2007","journal-title":"Proceedings of the Nutrition Society"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0054|cit55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.ejcn.1601539","article-title":"Lack of benefit of dietary advice to men with angina: results of a controlled trial","volume":"57","author":"Burr","year":"2003","journal-title":"European Journal of Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0055|cit56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00232-005-0784-1","article-title":"Is fish oil good or bad for heart disease? Two trials with apparently conflicting results","volume":"206","author":"Burr","year":"2005","journal-title":"Journal of Membrane Biology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-277X.2004.00506.x","article-title":"The long-term effect of dietary advice on the diet of men with angina: the diet and angina randomized trial","volume":"17","author":"Ness","year":"2004","journal-title":"Journal of Human Nutrition and Dietetics"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/1028415021000056069","article-title":"Advice to eat fish and mood: a randomised controlled trial in men with angina","volume":"6","author":"Ness","year":"2003","journal-title":"Nutritional Neuroscience"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/biof.1277","article-title":"Effects of n-3 PUFAs on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance","volume":"42","author":"Derosa","year":"2016","journal-title":"BioFactors (Oxford, England)"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1365-2362.1997.2240775.x","article-title":"Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year","volume":"27","author":"Blok","year":"1997","journal-title":"European Journal of Clinical Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0061|cit61","first-page":"189","article-title":"Influence of supplementation with n-3 fatty acids on different coronary risk factors in men: a placebo controlled study","volume":"54","author":"Deslypere","year":"1992","journal-title":"Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie"},{"issue":"10","key":"10.1002\/14651858.CD003177.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0022-2275(20)37132-7","article-title":"Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study","volume":"38","author":"Katan","year":"1997","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2014.09.001","article-title":"Dietary n-3\/long-chain n-3 polyunsaturated fatty acids for prevention of sporadic colorectal tumors: a randomized controlled trial in polypectomized participants","volume":"94","author":"Tokudome","year":"2015","journal-title":"Prostaglandins Leukotrienes and Essential Fatty Acids"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/jjco\/hyf108","article-title":"Rationale and study design of dietary intervention in patients polypectomized for tumors of the colorectum","volume":"32","author":"Tokudome","year":"2002","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0070|cit65","volume-title":"Dietary Intervention for Maintaining Sinus Rhythm Following Cardioversion for Atrial Fibrillation: a Randomised Controlled Trial [PhD thesis]","author":"Harrison","year":"2005"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0065|cit66","first-page":"6","article-title":"From pies to pilchards: dietary assistants increase consumption of oil rich fish","volume":"Suppl","author":"Harrison","year":"2000","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0066|cit67","unstructured":"Harrison RA Elton PJ Can an oil-rich fish diet improve treatment outcomes following cardioversion for atrial fibrillation? A randomised controlled trial. Study design and compliance International Society for the Study of Fatty Acids and Lipids (ISSFAL); 2002 May; Montreal, Canada 2002"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0067|cit68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mehy.2004.06.016","article-title":"Is there a role for long-chain omega3 or oil-rich fish in the treatment of atrial fibrillation?","volume":"64","author":"Harrison","year":"2005","journal-title":"Medical Hypotheses"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003177.pub3-BIB0068|cit69","first-page":"105","article-title":"Using community-based dietary assistants to increase the intake of oil-rich fish among older people","volume":"13","author":"Harrison","year":"2003","journal-title":"European Journal of Public Health"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0069|cit70","unstructured":"Harrison RA Suresh V Purnell B Roberts C Houghton P Miller J Can oil-rich fish sustain normal sinus rhythm after cardioversion for atrial fibrillation? An RCT (DISAF) Author supplied data 29 September 2010"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0071|cit71","first-page":"23","article-title":"Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Dodin","year":"2008","journal-title":"Nutrition (Burbank, CA)"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1210\/jc.2004-1148","article-title":"The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial","volume":"90","author":"Dodin","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003177.pub3-BIB0073|cit73","first-page":"1156","article-title":"Clinical outcomes of early initiation of pure eicosapentaenoic acid supplement after percutaneous coronary intervention in patients with acute coronary syndrome","volume":"35","author":"Doi","year":"2014","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijcard.2014.08.055","article-title":"Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: a randomized, controlled study","volume":"176","author":"Doi","year":"2014","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijcard.2016.11.105","article-title":"Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study","volume":"228","author":"Nosaka","year":"2017","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0076|cit76","doi-asserted-by":"crossref","unstructured":"Nosaka K Miyoshi T Okawa K Tsukuda S Sogo M Nishibe T Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study Journal of the American College of Cardiology 2016 573","DOI":"10.1016\/S0735-1097(16)30574-5"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/CS20020349","article-title":"Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1","volume":"105","author":"Berstad","year":"2003","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1743-7075-3-4","article-title":"Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine","volume":"3","author":"Eid","year":"2006","journal-title":"Nutrition & Metabolism"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-3-1","article-title":"Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine","volume":"3","author":"Eid","year":"2006","journal-title":"Nutrition and Metabolism"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2261-9-14","article-title":"Physical distress is associated with cardiovascular events in a high risk population of elderly men","volume":"9","author":"Einvik","year":"2009","journal-title":"BMC Cardiovascular Disorders"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jpsychores.2009.11.004","article-title":"The influence of long-term awareness of hyperlipidemia and of 3 years of dietary counselling on depression, anxiety, and quality of life","volume":"68","author":"Einvik","year":"2010","journal-title":"Journal of Psychosomatic Research"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/HJR.0b013e328339cc70","article-title":"A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk","volume":"17","author":"Einvik","year":"2010","journal-title":"European Journal of Cardiovascular Prevention & Rehabilitation"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.ejcn.1602327","article-title":"Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking study","volume":"60","author":"Ellingsen","year":"2006","journal-title":"European Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00365510701663350","article-title":"Long-term influence of diet and\/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease","volume":"68","author":"Furenes","year":"2008","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0085|cit85","first-page":"325","article-title":"Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia","volume":"13","author":"Hjerkinn","year":"2006","journal-title":"European Journal of Cardiovascular Prevention & Rehabilitation"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ajcn\/81.3.583","article-title":"Influence of long-term intervention with dietary counselling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia","volume":"81","author":"Hjerkinn","year":"2005","journal-title":"American Journal of Clinical Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1160\/TH03-12-0773","article-title":"The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene","volume":"91","author":"Lindman","year":"2004","journal-title":"Thrombosis & Haemostasis"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.metabol.2009.04.031","article-title":"Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men","volume":"58","author":"Troseid","year":"2009","journal-title":"Metabolism: Clinical & Experimental"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2009.09.028","article-title":"Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome","volume":"209","author":"Troseid","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology"},{"issue":"14","key":"10.1002\/14651858.CD003177.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.299.14.1690","article-title":"Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials","volume":"299","author":"Feagan","year":"2008","journal-title":"JAMA"},{"issue":"14","key":"10.1002\/14651858.CD003177.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.299.14.1690","article-title":"Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials","volume":"229","author":"Feagan","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1475-2891-10-117","article-title":"The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults","volume":"10","author":"Danthiir","year":"2011","journal-title":"Nutrition Journal"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3945\/jn.113.175695","article-title":"Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids","volume":"144","author":"Danthiir","year":"2014","journal-title":"Journal of Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0095|cit95","first-page":"S185","article-title":"Omega AF study: polyunsaturated fatty acids (PUFA) for prevention of atrial fibrillation relapse after successful external cardioversion","volume":"4","author":"Erdogan","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1055\/s-0029-1185301","article-title":"Beneficial effects of intravenously administered n-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study","volume":"57","author":"Heidt","year":"2009","journal-title":"Thoracic and Cardiovascular Surgeon"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"e005033","DOI":"10.1161\/JAHA.112.005033","article-title":"N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials","volume":"2","author":"Mariani","year":"2013","journal-title":"Journal of the American Heart Association"},{"issue":"18","key":"10.1002\/14651858.CD003177.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/CIRCULATIONAHA.105.549527","article-title":"Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake","volume":"112","author":"Leaf","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/HYPERTENSIONAHA.114.03179","article-title":"Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an alpha-linolenic acid-induced inhibition of soluble epoxide hydrolase","volume":"64","author":"Caligiuri","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/HYPERTENSIONAHA.116.07834","article-title":"Dietary flaxseed reduces central aortic blood pressure without cardiac involvement but through changes in plasma oxylipins","volume":"68","author":"Caligiuri","year":"2016","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0101|cit101","first-page":"1339","article-title":"Flaxseed lignan metabolites elicit antihypertensive effects in pad patients in the flax-pad trial","volume":"63","author":"Edel","year":"2013","journal-title":"Annals of Nutrition and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3945\/jn.114.204594","article-title":"Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease","volume":"145","author":"Edel","year":"2015","journal-title":"Journal of Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cct.2011.05.005","article-title":"The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial","volume":"32","author":"Leyva","year":"2011","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0104|cit104","first-page":"15","article-title":"The use of dietary flaxseed to promote cardiovascular health","volume":"211","author":"Pierce","year":"2014","journal-title":"Acta Physiologica"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0105|cit105","first-page":"201","article-title":"The clinical use of flaxseed as a powerful nutritional intervention to treat cardiovascular disease","volume":"126","author":"Pierce","year":"2013","journal-title":"Cardiology (Switzerland)"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/HYPERTENSIONAHA.113.02094","article-title":"Potent antihypertensive action of dietary flaxseed in hypertensive patients","volume":"62","author":"Rodriguez-Leyva","year":"2013","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0107|cit107","unstructured":"Macchia A Grancelli H Varini S Nul D Ferrante D Mariani J Late-breaking clinical trials: treatments for prevention of cardiovascular events: a population perspective Circulation 2012 2780 1"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2012.11.021","article-title":"Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (randomized trial to assess efficacy of PUFA for the maintenance of sinus rhythm in persistent atrial fibrillation) trial","volume":"61","author":"Macchia","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ahj.2008.10.027","article-title":"The rationale and design of the FORomegaARD trial: a randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation","volume":"157","author":"Macchia","year":"2009","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00198-015-3438-x","article-title":"Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial","volume":"27","author":"Chen","year":"2016","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0111|cit111","doi-asserted-by":"crossref","unstructured":"Hill C Lester SE Jones G Response to 'Low-dose versus high-dose fish oil for pain reduction and function improvement in patients with knee osteoarthritis' by Chen et al Annals of the Rheumatic Diseases 2016 e8","DOI":"10.1136\/annrheumdis-2015-208781"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/annrheumdis-2014-207169","article-title":"Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose","volume":"75","author":"Hill","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0114|cit113","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ccd.1810280407","article-title":"A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following ptca","volume":"28","author":"Franzen","year":"1993","journal-title":"Catheterization and Cardiovascular Diagnosis"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0113|cit114","first-page":"134","article-title":"Long-term effects of low dosage fish oil on serum lipids and lipoproteins","volume":"88","author":"Franzen","year":"1993","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0115|cit115","first-page":"A1269. Abstract","article-title":"Omega-3 fatty acids effects on carotid IMT in metabolic syndrome","volume":"130","author":"Gill","year":"2014","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacl.2012.04.055","article-title":"Omega-3 fatty acids improve dyslipidemia but not inflammatory markers in metabolic syndrome","volume":"6","author":"Gill","year":"2012","journal-title":"Journal of Clinical Lipidology"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurjhf\/hft103","article-title":"N-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial","volume":"15","author":"Aleksova","year":"2013","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0118|cit118","first-page":"442","article-title":"Prevalence and prognostic impact of chronic obstructive pulmonary disease in patients with chronic heart failure. Data from the GISSI-Heart Failure trial","volume":"18","author":"Canepa","year":"2016","journal-title":"European Journal of Heart Failure"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurjhf\/hfr023","article-title":"Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting","volume":"13","author":"Cowie","year":"2011","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0120|cit120","first-page":"279","article-title":"Antiarrhythmic effects of n-3 PUFA in patients with heart failure and an implantable cardioverter defibrillator in the GISSI-HF trial","volume":"30","author":"Finzi","year":"2009","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ahj.2010.10.032","article-title":"Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial","volume":"161","author":"Finzi","year":"2011","journal-title":"American Heart Journal"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurjhf\/hfq172","article-title":"Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial","volume":"12","author":"Ghio","year":"2010","journal-title":"European Journal of Heart Failure"},{"issue":"9645","key":"10.1002\/14651858.CD003177.pub3-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S01406736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"issue":"21 Suppl 1","key":"10.1002\/14651858.CD003177.pub3-BIB0124|cit124","first-page":"A14829","article-title":"Effect of n-3PUFA on heart rate variability. Data from the GISSI-HF holter substudy","volume":"124","author":"Rovere","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/eurjhf\/hfs126","article-title":"Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial","volume":"14","author":"Rovere","year":"2012","journal-title":"European Journal of Heart Failure"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.hrthm.2012.10.035","article-title":"n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy","volume":"10","author":"Rovere","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0127|cit127","first-page":"919","article-title":"Circulating levels of n-3 polyunsaturated fatty acids in patients with chronic heart failure. Data from the GISSI-HF trial","volume":"32","author":"Latini","year":"2011","journal-title":"European Heart Journal"},{"issue":"19","key":"10.1002\/14651858.CD003177.pub3-BIB0128|cit128","first-page":"232736","article-title":"Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial","volume":"30","author":"Maggioni","year":"2009","journal-title":"Eupropean Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0129|cit129","first-page":"165","article-title":"Time course analysis of the effect of n-3 PUFA on fatal and non fatal arrhythmias in heart failure: secondary results of the GISSI-HF trial","volume":"30","author":"Marchioli","year":"2009","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0130|cit130","first-page":"432","article-title":"Time course analysis of the effect of n-3 PUFA on fatal and non fatal heart failure: secondary results of the GISSI-HF trial","volume":"30","author":"Marchioli","year":"2009","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0131|cit131","first-page":"1026","article-title":"Prognostic ability of a Mediterranean dietary score in heart failure: preliminary analysis of the GISSI-Heart failure Trial","volume":"30","author":"Marchioli","year":"2009","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0132|cit132","first-page":"426","article-title":"Effect of n-3 PUFA in heart failure patients with different dietary habits: preliminary results of the GISSI-heart failure trial","volume":"30","author":"Marchioli","year":"2009","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0133|cit133","first-page":"707","article-title":"Effect of n-3 PUFA according to fish intake: preliminary results of GISSI-Heart Failure","volume":"30","author":"Marchioli","year":"2009","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1586\/erc.09.70","article-title":"Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial","volume":"7","author":"Marchioli","year":"2009","journal-title":"Expert Reviews Cardiovascular Therapys"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0135|cit135","first-page":"65","article-title":"Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial","volume":"3","author":"Masson","year":"2010","journal-title":"Circulation: Heart Failure"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ahj.2012.10.021","article-title":"Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality","volume":"165","author":"Masson","year":"2013","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ahj.2010.05.015","article-title":"Prognostic value of osteoprotegerin in chronic heart failure: the GISSI-HF trial","volume":"160","author":"R\u00f8ysland","year":"2010","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ejheart.2004.03.001","article-title":"Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure","volume":"6","author":"Tavazzi","year":"2004","journal-title":"European Journal of Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00019053-200119040-00008","article-title":"Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial","volume":"19","author":"Franzosi","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial","volume":"354","author":"GISSI-Prevenzione Investigators","year":"1999","journal-title":"Lancet"},{"issue":"Suppl D","key":"10.1002\/14651858.CD003177.pub3-BIB0144|cit141","doi-asserted-by":"crossref","first-page":"D85","DOI":"10.1016\/S1520-765X(01)90126-9","article-title":"Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione Trial","volume":"3","author":"Marchioli","year":"2001","journal-title":"European Heart Journal Supplements"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0141|cit142","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0142|cit143","first-page":"933","article-title":"The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico","volume":"23","author":"Marchioli","year":"1993","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0143|cit144","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/euhj.1999.1971","article-title":"The results of the GISSI-Prevenzione trial in the general framework of secondary prevention","volume":"21","author":"Marchioli","year":"2000","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-125-7-199610010-00001","article-title":"Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and \"normal\" cholesterol levels. A randomized, placebo-controlled trial","volume":"125","author":"Pasternak","year":"1996","journal-title":"Annals of Internal Medicine"},{"issue":"8931","key":"10.1002\/14651858.CD003177.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(94)90506-1","article-title":"Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients","volume":"344","author":"Sacks","year":"1994","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/0735-1097(95)00095-L","article-title":"Controlled trial of fish oil for regression of human coronary atherosclerosis","volume":"25","author":"Sacks","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0148|cit148","volume-title":"Dietary Manipulation and Weight Management [PhD thesis]","author":"Tan","year":"2010"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/ejcn.2009.19","article-title":"Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes","volume":"63","author":"Tapsell","year":"2009","journal-title":"European Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejheart.2005.12.003","article-title":"Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE","volume":"8","author":"Cleland","year":"2006","journal-title":"European Journal of Heart Failure"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1253\/circj.CJ-09-0520","article-title":"Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease","volume":"74","author":"Ishikawa","year":"2010","journal-title":"Circulation Journal"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.5876","article-title":"Relationships between plasma fatty acid composition and coronary artery disease","volume":"18","author":"Itakura","year":"2011","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"673","DOI":"10.5551\/jat.11593","article-title":"The change in low-density lipoprotein cholesterol concentration is positively related to plasma docosahexaenoic acid but not eicosapentaenoic acid","volume":"19","author":"Itakura","year":"2012","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1253\/circj.CJ-08-1197","article-title":"Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Secondary prevention analysis from JELIS","volume":"73","author":"Matsuzaki","year":"2009","journal-title":"Circulation Journal"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.atherosclerosis.2009.03.029","article-title":"Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)","volume":"206","author":"Oikawa","year":"2009","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1253\/circj.CJ-09-0746","article-title":"Clinical importance of adherence to treatment with eicosapentaenoic acid by patients with hypercholesterolemia","volume":"74","author":"Origasa","year":"2010","journal-title":"Circulation Journal"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2008.06.003","article-title":"Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)","volume":"200","author":"Saito","year":"2008","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1161\/STROKEAHA.107.509455","article-title":"Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial","volume":"39","author":"Tanaka","year":"2008","journal-title":"Stroke"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1253\/circj.CJ-10-0449","article-title":"Eicosapentaenoic acid as the gold standard for patients with peripheral artery disease? Subanalysis of the JELIS trial","volume":"74","author":"Yamanouchi","year":"2010","journal-title":"Circulation Journal"},{"issue":"9567","key":"10.1002\/14651858.CD003177.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-8703(03)00367-3","article-title":"Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolaemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)","volume":"146","author":"Yokoyama","year":"2003","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.hrthm.2011.11.034","article-title":"Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion","volume":"9","author":"Kumar","year":"2012","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1016\/j.ijcard.2013.06.030","article-title":"Effects of long-term omega-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: results from a prospective randomised study","volume":"168","author":"Kumar","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3109\/00365529609010352","article-title":"Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial","volume":"31","author":"Lorenz-Meyer","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12603-012-0046-8","article-title":"Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial)","volume":"16","author":"Carrie","year":"2012","journal-title":"Journal of Nutrition, Health & Aging"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"151","DOI":"10.14283\/jpad.2016.94","article-title":"Neuropsychological profile of \"cognitive frailty\" subjects in MAPT study","volume":"3","author":"Delrieu","year":"2016","journal-title":"Journal of Prevention of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/j.jalz.2011.05.1217","article-title":"Multidomain alzheimer's disease preventive trial: florbetapir ancillary study","volume":"1","author":"Delrieu","year":"2011","journal-title":"Alzheimer's and Dementia"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0169|cit169","unstructured":"Fougere B Barreto PD Goisser S Soriano G Guyonnet S Andrieu S Red blood cell membrane omega-3 fatty acid levels and physical performance: cross-sectional data from the MAPT study Clinical Nutrition 1 4 10.1016\/j.clnu.2017.04.005"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jalz.2009.05.496","article-title":"The multidomain Alzheimer preventive trial (MAPT): a new approach for the prevention of Alzheimer's disease","volume":"S4-02-05","author":"Gillette","year":"2009","journal-title":"Alzheimer's & Dementia"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jalz.2009.01.008","article-title":"Commentary on \"A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.\" The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease","volume":"5","author":"Gillette-Guyonnet","year":"2009","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0172|cit172","first-page":"S97","article-title":"MAPT study: a 3-year randomized trial of omega 3 and\/or multidomain intervention for the prevention of cognitive decline in frail elderly subjects-rationale, design and baseline data","volume":"1","author":"Gillette-Guyonnet","year":"2011","journal-title":"Alzheimer's & Dementia"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0173|cit173","first-page":"13","article-title":"MAPT Study: a multidomain approach for preventing ALzheimer's disease: design and baseline data","volume":"1","author":"Vellas","year":"2014","journal-title":"Journal of Prevention of Alzheimers Disease"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jalz.2015.08.151","article-title":"MAPT (multi-domain Alzheimer's prevention trial): Results at 36 months","volume":"1","author":"Vellas","year":"2015","journal-title":"Alzheimer's & Dementia"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0175|cit175","first-page":"812","article-title":"MAPT (multidomain Alzheimer preventive trial) imaging (MRI, FDG-PET, amyloid-PET) data","volume":"16","author":"Vellas","year":"2012","journal-title":"Journal of Nutrition, Health and Aging"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ajcn\/75.2.221","article-title":"Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean alpha-linolenic enriched Groningen dietary intervention (MARGARIN) study","volume":"75","author":"Bemelmans","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S1368980000000318","article-title":"Impact of Mediterranean diet education versus posted leaflet on dietary habits and serum cholesterol in a high risk population for cardiovascular disease","volume":"3","author":"Bemelmans","year":"2000","journal-title":"Public Health Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0021-9150(01)00747-X","article-title":"Change in saturated fat intake is associated with progression of carotid and femoral intima-media thickness, and with levels of soluble intercellular adhesion molecule-1","volume":"163","author":"Bemelmans","year":"2002","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/sj.ejcn.1601938","article-title":"Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis","volume":"58","author":"Bemelmans","year":"2004","journal-title":"European Journal of Clinical Nutrition"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.ejcn.1601102","article-title":"Associations of alpha-linolenic acid and linoleic acid with risk factors for coronary heart disease","volume":"54","author":"Bemelmans","year":"2000","journal-title":"European Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/her\/15.5.635","article-title":"Impact of group nutrition education and surplus value of Prochaska based stage-matched information on health-related cognitions and on Mediterranean nutrition behaviour","volume":"15","author":"Siero","year":"2000","journal-title":"Health Education Research"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1194\/jlr.P032276","article-title":"Genetic variation at the FADS1-FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement","volume":"54","author":"Al-Hilal","year":"2013","journal-title":"Journal of Lipid Research"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3945\/jn.113.185108","article-title":"Interaction between a CSK gene variant and fish oil intake influences blood pressure in healthy adults","volume":"144","author":"AlSaleh","year":"2014","journal-title":"Journal of Nutrition"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3945\/jn.112.172585","article-title":"Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals","volume":"143","author":"Alsaleh","year":"2013","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1016\/j.ijcard.2013.06.153","article-title":"Effect of low doses of long chain n-3 polyunsaturated fatty acids on sleep-time heart rate variability: a randomized, controlled trial","volume":"168","author":"Hall","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0186|cit186","first-page":"S146","article-title":"Effect of low doses of long chain n-3 PUFA intake on daytime heart rate variability: results from the MARINA study","volume":"1","author":"Pinto","year":"2015","journal-title":"European Journal of Preventive Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3945\/ajcn.111.018036","article-title":"Effect of low doses of long-chain n-3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial","volume":"94","author":"Sanders","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0188|cit188","unstructured":"Sanders TAB Chowienczyk PJ Hall W Lewis F Seed P Maniou Z The influences of increasing intakes of EPA and DHA on vascular function and risk factors for cardiovascular disease Food Standards Agency Project N02041. Final Report 2011"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0189|cit189","doi-asserted-by":"publisher","first-page":"e002771","DOI":"10.1161\/JAHA.115.002771","article-title":"Effects of diet composition and insulin resistance status on plasma lipid levels in a weight loss intervention in women","volume":"5","author":"Le","year":"2016","journal-title":"Journal of the American Heart Association"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.metabol.2016.07.008","article-title":"Effects of diet composition on weight loss, metabolic factors and biomarkers in a 1-year weight loss intervention in obese women examined by baseline insulin resistance status","volume":"65","author":"Rock","year":"2016","journal-title":"Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2006.03.005","article-title":"Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes","volume":"191","author":"Mita","year":"2007","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1167\/iovs.14-13916","article-title":"Circulating omega-3 fatty acids and neovascular age-related macular degeneration","volume":"55","author":"Merle","year":"2014","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"e0130816","DOI":"10.1371\/journal.pone.0130816","article-title":"CFH Y402H and ARMS2 A69S polymorphisms and oral supplementation with docosahexaenoic acid in neovascular age-related macular degeneration patients: the NAT2 study","volume":"10","author":"Merle","year":"2015","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"e0149219","DOI":"10.1371\/journal.pone.0149219","article-title":"Dynamic drusen remodelling in participants of the nutritional AMD treatment-2 (NAT-2) randomized trial","volume":"11","author":"Querques","year":"2016","journal-title":"PLOS ONE"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.ophtha.2013.01.005","article-title":"Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the nutritional AMD treatment 2 study","volume":"120","author":"Souied","year":"2013","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD003177.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.111.022194","article-title":"N-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study","volume":"124","author":"Nodari","year":"2011","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0197|cit197","unstructured":"NCT01223703 PUFAs and left ventricular function in heart failure (CS-PUFA-02) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01223703"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0198|cit198","first-page":"850","article-title":"Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in heart failure patients","volume":"31","author":"Nodari","year":"2010","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jacc.2010.11.017","article-title":"Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy","volume":"57","author":"Nodari","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"21 Suppl 1","key":"10.1002\/14651858.CD003177.pub3-BIB0200|cit200","first-page":"A17431","article-title":"Plasma levels of n-3 polyunsaturated fatty acids and risk of hospitalization in patients with non-ischemic cardiomyopathy","volume":"126","author":"Nodari","year":"2012","journal-title":"Circulation. Conference: American Heart Association"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sc.2014.30","article-title":"Does consumption of polyunsaturated fatty acids influence on neurorehabilitation in traumatic spinal cord-injured individuals? A double-blinded clinical trial","volume":"52","author":"Norouzi Javidan","year":"2014","journal-title":"Spinal Cord"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1179\/2045772314Y.0000000251","article-title":"Omega-3 fatty acids' effect on leptin and adiponectin concentrations in patients with spinal cord injury: a double-blinded randomized clinical trial","volume":"38","author":"Sabour","year":"2015","journal-title":"Journal of Spinal Cord Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0204|cit203","first-page":"1033","article-title":"The effect of unsaturated fatty acids on the incidence of coronary infarction, etc","volume":"87","author":"Natvig","year":"1967","journal-title":"Tidsskrift for Den Norske Laegeforening"},{"issue":"Suppl","key":"10.1002\/14651858.CD003177.pub3-BIB0203|cit204","first-page":"1","article-title":"A controlled trial of the effect of linolenic acid on incidence of coronary heart disease. The Norwegian vegetable oil experiment of 1965-66","volume":"105","author":"Natvig","year":"1968","journal-title":"Scandinavian Journal of Clinical & Laboratory Investigation"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0205|cit205","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000207441","article-title":"Is antioxidant and n-3 supplementation able to improve functional status in post-stroke patients? Results from the Nutristroke Trial","volume":"27","author":"Garbagnati","year":"2009","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0206|cit206","first-page":"559","article-title":"Randomised placebo controlled trial of MAXEPA and aspirin\/persantin after successful coronary angioplasty","volume":"17","author":"Ilsey","year":"1987","journal-title":"Australian & New Zealand Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1445-5994.1990.tb01311.x","article-title":"Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty","volume":"20","author":"Nye","year":"1990","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1160\/TH05-07-0497","article-title":"Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction","volume":"95","author":"Aarsetoy","year":"2006","journal-title":"Thrombosis & Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/s-0037-1613583","article-title":"Changes in tissue factor and activated factor XII following an acute myocardial infarction were uninfluenced by high doses of n-3 polyunsaturated fatty acids","volume":"89","author":"Grundt","year":"2003","journal-title":"Thrombosis & Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clnu.2003.09.005","article-title":"Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction","volume":"23","author":"Grundt","year":"2004","journal-title":"Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000073852","article-title":"Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties","volume":"33","author":"Grundt","year":"2003","journal-title":"Pathophysiology of Haemostasis & Thrombosis"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.ejcn.1601730","article-title":"Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction","volume":"57","author":"Grundt","year":"2003","journal-title":"European Journal of Clinical Nutrition"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003177.pub3-BIB0213|cit213","first-page":"A17245","article-title":"The effect on vitamin D levels of long-term high-dose treatment with a concentrated omega-3 compound (Omacor\/Lovaza) in patients hospitalized with a myocardial infarction","volume":"130","author":"Naesgaard","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ajcn\/74.1.50","article-title":"Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol","volume":"74","author":"Nilsen","year":"2001","journal-title":"American Journal of Clinical Nutrition"},{"issue":"21 Suppl 1","key":"10.1002\/14651858.CD003177.pub3-BIB0215|cit215","first-page":"A13464","article-title":"Pentraxin 3 is uninfluenced by high doses of concentrated omega-3 fatty acids administered for 12 months following an acute myocardial infarction","volume":"126","author":"Poenitz","year":"2012","journal-title":"Circulation. Conference: American Heart Association"},{"issue":"21","key":"10.1002\/14651858.CD003177.pub3-BIB0216|cit216","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0217|cit217","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10557-006-0495-6","article-title":"Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study","volume":"20","author":"Rauch","year":"2006","journal-title":"Cardiovascular Drugs Therapy"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"e1037","DOI":"10.4088\/JCP.13m08453","article-title":"Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial","volume":"74","author":"Zimmer","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3945\/ajcn.2009.29121","article-title":"Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial","volume":"91","author":"Dangour","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12603-009-0057-2","article-title":"Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study","volume":"13","author":"Dangour","year":"2009","journal-title":"Journal of Nutrition, Health & Aging"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ophtha.2012.09.043","article-title":"N-3 fatty acids and retinal function","volume":"120","author":"Dangour","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2891-5-20","article-title":"A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636]","volume":"5","author":"Dangour","year":"2006","journal-title":"Nutrition Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0223|cit223","unstructured":"ISRCTN72331636 The OPAL Study: Older People And n-3 Long-chain polyunsaturated fatty acids http:\/\/www.isrctn.com\/ISRCTN72331636"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0224|cit224","first-page":"A72","article-title":"Cancer outcomes in patients with dysglycemia on basal insulin: results of the Origin trial","volume":"62","author":"Bordeleau","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2337\/dc13-1468","article-title":"The association of basal insulin glargine and\/or n-3 fatty acids with incident cancers in patients with dysglycemia","volume":"37","author":"Bordeleau","year":"2014","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.2337\/dc12-2129","article-title":"Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE)","volume":"36","author":"Lonn","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/eurheartj\/eht308.1966","article-title":"Effects of n-3 fatty acids on long-term outcomes of high risk patients with type 2 diabetes mellitus or IGF\/IGT with a recent myocardial infarction","volume":"34","author":"Maggioni","year":"2013","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","author":"Bosch","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0229|cit229","first-page":"26-32, 32","article-title":"Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)","volume":"155","author":"Gerstein","year":"2008","journal-title":"American Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2337\/dc15-1676","article-title":"Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE)","volume":"39","author":"Punthakee","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacl.2013.09.002","article-title":"Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized long-term (ORL) study","volume":"7","author":"Tatsuno","year":"2013","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/eurheartj\/eht309.P4185","article-title":"Effects of long-term treatment with omega-3 polyunsaturated fatty acids (Lotriga) on atherogenic lipoproteins in hypertriglyceridemia:results from a phase 3 randomized, open-label, 1-year study","volume":"34","author":"Tatsuno","year":"2013","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0234|cit234","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5152\/akd.2011.080","article-title":"N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study","volume":"11","author":"\u00d6zaydin","year":"2011","journal-title":"Anadolu Kardiyoloji Dergisi"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003177.pub3-BIB0235|cit235","first-page":"2","article-title":"Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose","volume":"42","author":"Proudman","year":"2012","journal-title":"Internal Medicine Journal"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1017\/S0007114515002718","article-title":"Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis","volume":"114","author":"Proudman","year":"2015","journal-title":"British Journal of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/annrheumdis-2013-204145","article-title":"Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use","volume":"74","author":"Proudman","year":"2015","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1212\/01.wnl.0000169025.09670.6d","article-title":"Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial","volume":"65","author":"Puri","year":"2005","journal-title":"Neurology"},{"issue":"23","key":"10.1002\/14651858.CD003177.pub3-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1001\/jama.293.23.2884","article-title":"Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial","volume":"293","author":"Raitt","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0240|cit240","doi-asserted-by":"publisher","first-page":"709493","DOI":"10.1155\/2013\/709493","article-title":"Efficacy of fish oil on serum of TNF \u03b1 , IL-1 \u03b2 , and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b","volume":"2013","author":"Ramirez-Ramirez","year":"2013","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0241|cit241","first-page":"145","article-title":"Effect of fish oil on glutathione redox system in multiple sclerosis","volume":"5","author":"Sorto-Gomez","year":"2016","journal-title":"American Journal of Neurodegenerative Disease"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"827286","DOI":"10.1155\/2011\/827286","article-title":"Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids","volume":"2011","author":"Olendzki","year":"2011","journal-title":"Evidence-Based Complementary & Alternative Medicine: eCAM"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"857456","DOI":"10.1155\/2014\/857456","article-title":"Treatment of rheumatoid arthritis with marine and botanical oils: an 18-month, randomized, and double-blind trial","volume":"2014","author":"Reed","year":"2014","journal-title":"Evidence-Based Complementary & Alternative Medicine: eCAM"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1745-6215-11-68","article-title":"Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice","volume":"11","author":"Rischio and Prevenzione Investigators","year":"2010","journal-title":"Trials"},{"issue":"19","key":"10.1002\/14651858.CD003177.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1205409","article-title":"N-3 fatty acids in patients with multiple cardiovascular risk factors","volume":"368","author":"Roncaglioni","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003177.pub3-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1093\/fampra\/cmn079","article-title":"Towards evidence-based practice via practice-based evidence: the Italian experience","volume":"25","author":"Visentin","year":"2008","journal-title":"Family Practice"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0247|cit247","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/003655101316911387","article-title":"Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy","volume":"61","author":"Myrup","year":"2001","journal-title":"Scandinavian Journal of Clinical & Laboratory Investigation"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diacare.19.11.1214","article-title":"Fish oil in diabetic nephropathy","volume":"19","author":"Rossing","year":"1996","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1940-6207.CAPR-15-0235","article-title":"Influence of obesity on breast density reduction by omega-3 fatty acids: evidence from a randomized clinical trial","volume":"9","author":"Sandhu","year":"2016","journal-title":"Cancer Prevention Research"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ejcn.2012.60","article-title":"Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial","volume":"66","author":"Signori","year":"2012","journal-title":"European Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0008-6363(02)00229-8","article-title":"Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries","volume":"54","author":"Angerer","year":"2002","journal-title":"Cardiovascular Research"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0252|cit252","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-130-7-199904060-00003","article-title":"The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial","volume":"130","author":"Schacky","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD003177.pub3-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1007\/s11745-001-0689-5","article-title":"The effect of n-3 fatty acids on coronary atherosclerosis: results from SCIMO, an angiographic study, background and implications","volume":"36","author":"Schacky","year":"2001","journal-title":"Lipids"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0254|cit254","unstructured":"NCT00090402 Fish oil and alpha lipoic acid in treating Alzheimer's Disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00090402"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-130722","article-title":"A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease","volume":"38","author":"Shinto","year":"2014","journal-title":"Journal of Alzheimer's Disease: JAD"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/00365519509104966","article-title":"Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation","volume":"55","author":"Eritsland","year":"1995","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9149(97)89130-8","article-title":"Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency","volume":"77","author":"Eritsland","year":"1996","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0258|cit258","first-page":"29","article-title":"Effect of supplementation with n-3 fatty acids on graft patency in patients undergoing coronary artery bypass operation. Results from SHOT study","volume":"15","author":"Eritsland","year":"1994","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/ajcn\/61.4.831","article-title":"Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease","volume":"61","author":"Eritsland","year":"1995","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00001721-199502000-00003","article-title":"Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease","volume":"6","author":"Eritsland","year":"1995","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0262|cit261","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0268-9499(05)80029-3","article-title":"Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids","volume":"8","author":"Eritsland","year":"1994","journal-title":"Fibrinolysis"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0261|cit262","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/00365519409087522","article-title":"Long-term effects of n-3 fatty acids on serum lipids and glycaemic control","volume":"54","author":"Eritsland","year":"1994","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0049-3848(92)90464-L","article-title":"Long-term effects of fish oil supplementation in patients with coronary artery disease: influence on lipoproteins, coagulation and fibrinolysis","volume":"65","author":"Eritsland","year":"1992","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0264|cit264","first-page":"1065","article-title":"Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids","volume":"69","author":"Eritsland","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0049-3848(95)93837-P","article-title":"Effect of long-term, moderate-dose supplementation with omega-3 fatty acids on monocyte procoagulant activity and release of interleukin-6 in patients with coronary artery disease","volume":"77","author":"Eritsland","year":"1995","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0261-5614(13)60173-9","article-title":"Effect of omega 3 fatty acids in patients with hypertension and atrial fibrillation","volume":"32","author":"Sianni","year":"2013","journal-title":"Clinical Nutrition"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0267|cit267","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/jhh.2016.10","article-title":"Identification of dietary patterns associated with blood pressure in a sample of overweight Australians","volume":"30","author":"Anil","year":"2016","journal-title":"Journal of Human Hypertension"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0269|cit268","doi-asserted-by":"crossref","first-page":"733.9","DOI":"10.1096\/fasebj.24.1_supplement.733.9","article-title":"Effect of dietary restriction and n-3 PUFA supplementation on insulin resistance in obese adults","volume":"24","author":"Tapsell","year":"2010","journal-title":"FASEB Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0268|cit269","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1186\/1471-2458-13-1231","article-title":"Foods, nutrients or whole diets: effects of targeting fish and LCn3PUFA consumption in a 12mo weight loss trial","volume":"13","author":"Tapsell","year":"2013","journal-title":"BMC Public Health"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003177.pub3-BIB0270|cit270","first-page":"67","article-title":"Baseline characteristics of volunteers in the smart clinical trial: associations between habitual physical activity and lifestyle disease risk factors.","volume":"67","author":"Zhang","year":"2010","journal-title":"Nutrition and Dietetics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003177.pub3-BIB0271|cit271","first-page":"79","article-title":"Rationale and design of a clinical trial on n-3 fatty acids and cardiac arrhythmia (SOFA)","volume":"45","author":"Brouwer","year":"2001","journal-title":"Annals of Nutrition & Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehp003","article-title":"Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators","volume":"30","author":"Brouwer","year":"2009","journal-title":"European Heart Journal"},{"issue":"22","key":"10.1002\/14651858.CD003177.pub3-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.295.22.2613","article-title":"Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the study on omega-3 fatty acids and ventricular arrhythmia (SOFA) randomized trial","volume":"295","author":"Brouwer","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.ejcn.1601695","article-title":"Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA","volume":"57","author":"Brouwer","year":"2003","journal-title":"European Journal of Clinical Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/09637486.2010.487480","article-title":"Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study","volume":"61","author":"Sofi","year":"2010","journal-title":"International Journal of Food Sciences and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.atherosclerosis.2013.03.017","article-title":"Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease","volume":"228","author":"Ahluwalia","year":"2013","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3945\/ajcn.112.035253","article-title":"Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and\/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial","volume":"96","author":"Andreeva","year":"2012","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3945\/ajcn.110.006320","article-title":"Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial","volume":"94","author":"Andreeva","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"e84844","DOI":"10.1371\/journal.pone.0084844","article-title":"B vitamin and\/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial","volume":"9","author":"Andreeva","year":"2014","journal-title":"PLOS ONE"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archinternmed.2011.1450","article-title":"B vitamin and\/or omega-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and\/or omega-3 fatty acids (SU.FOL.OM3) randomized trial","volume":"172","author":"Andreeva","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijcard.2012.01.060","article-title":"Cardiovascular effects of B-vitamins and\/or n-3 fatty acids: the SU.FOL.OM3 trial","volume":"167","author":"Blacher","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/jhh.2014.44","article-title":"Blood pressure variability: cardiovascular risk integrator or independent risk factor","volume":"29","author":"Blacher","year":"2015","journal-title":"Journal of Human Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"e92548","DOI":"10.1371\/journal.pone.0092548","article-title":"Baseline plasma fatty acids profile and incident cardiovascular events in the SU.FOL.OM3 trial: the evidence revisited","volume":"9","author":"Fezeu","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0285|cit284","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1745-6215-9-35","article-title":"The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and\/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics","volume":"9","author":"Galan","year":"2008","journal-title":"Trials"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0286|cit285","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1745-6215-9-35","article-title":"The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and\/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics","volume":"9","author":"Galan","year":"2008","journal-title":"Trials"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0287|cit286","first-page":"207","article-title":"The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and\/or omega3 fatty acid supplements in the prevention of recurrent ischemic events","volume":"21","author":"Galan","year":"2009","journal-title":"Sang Thrombose Vaisseaux"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0284|cit287","first-page":"207","article-title":"The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and\/or omega3 fatty acid supplements in the prevention of recurrent ischemic events","volume":"21","author":"Galan","year":"2009","journal-title":"Sang Thrombose Vaisseaux"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0288|cit288","doi-asserted-by":"publisher","first-page":"c6273","DOI":"10.1136\/bmj.c6273","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial","volume":"341","author":"Galan","year":"2010","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0289|cit289","first-page":"428","article-title":"Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and\/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries","volume":"7","author":"Galan","year":"2003","journal-title":"Journal of Nutrition, Health and Aging"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12603-011-0023-7","article-title":"Thirteen-year prospective study between fish consumption, long-chain N-3 fatty acids intakes and cognitive function","volume":"15","author":"Kesse-Guyot","year":"2011","journal-title":"Journal of Nutrition, Health and Aging"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1017\/S0007114511003692","article-title":"Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD","volume":"107","author":"Szabo De Edelenyi","year":"2012","journal-title":"British Journal of Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/HJR.0b013e3283383f47","article-title":"Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?","volume":"17","author":"Vesin","year":"2010","journal-title":"European Journal of Cardiovascular Prevention & Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.ejcn.1601871","article-title":"Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases","volume":"58","author":"Bree","year":"2004","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yrtph.2016.05.030","article-title":"Clinical safety evaluation of marine oil derived from Calanus finmarchicus","volume":"80","author":"Tande","year":"2016","journal-title":"Regulatory Toxicology and Pharmacology: RTP"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.jrn.2006.04.022","article-title":"Implications of chronic kidney disease for dietary treatment of cardiovascular disease","volume":"16","author":"Packard","year":"2006","journal-title":"Journal of Renal Nutrition"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.amjcard.2008.01.038","article-title":"Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial)","volume":"101","author":"Tuttle","year":"2008","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0297|cit297","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1017\/S0007114517001957","article-title":"Favourable nutrient intake and displacement with long-term walnut supplementation among elderly: results of a randomised trial","volume":"118","author":"Bitok","year":"2017","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0298|cit298","doi-asserted-by":"crossref","unstructured":"Bitok E Rajaram S Ros E Does a daily walnut supplement given for a year result in body weight gain? FASEB Journal 2016 1157.5","DOI":"10.1096\/fasebj.30.1_supplement.1157.5"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0299|cit299","doi-asserted-by":"crossref","unstructured":"Huey L Bitok E Kazzi N Dietary compliance of walnut or no walnut intake in a 1-year randomized intervention trial among free-living elderly in the Walnuts and Healthy Aging Study (WAHA) FASEB Journal 2016 1157.10","DOI":"10.1096\/fasebj.30.1_supplement.1157.10"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0300|cit300","first-page":"333","article-title":"The Walnuts and Healthy Aging Study (WAHA): protocol for a nutritional intervention trial with walnuts on brain aging","volume":"8","author":"Rajaram","year":"2016","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0301|cit301","doi-asserted-by":"crossref","unstructured":"Ros Emilio Rajaram Sujatha Sala-Vila Aleix Effect of a 1-year walnut supplementation on blood lipids among older individuals: findings from the Walnuts and Healthy Aging (WAHA) study FASEB Journal 2016 293.4","DOI":"10.1096\/fasebj.30.1_supplement.293.4"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0302|cit302","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.plefa.2005.05.024","article-title":"Low fat dietary intervention with n-3 fatty acid supplementation in multiple sclerosis patients","volume":"73","author":"Weinstock-Guttman","year":"2005","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2015.12.028","article-title":"Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression","volume":"246","author":"Bhatia","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/ATVBAHA.114.303034","article-title":"Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease","volume":"34","author":"Byrne","year":"2014","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0305|cit305","doi-asserted-by":"crossref","unstructured":"Byrne CD Targher G Time to replace assessment of liver histology with MR-based imaging tests to assess efficacy of interventions for nonalcoholic fatty liver disease Gastroenterology 2016 7 10","DOI":"10.1053\/j.gastro.2015.11.016"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00125-016-3966-8","article-title":"Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex evaluation of fatty liver and cardiovascular markers in NAFLD with omacor therapy trial (WELCOME) trial","volume":"59","author":"Clough","year":"2016","journal-title":"Diabetologia"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ejcn.2017.9","article-title":"Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study","volume":"71","author":"Hodson","year":"2017","journal-title":"European Journal of Clinical Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0308|cit308","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s00125-015-3628-2","article-title":"Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial","volume":"58","author":"McCormick","year":"2015","journal-title":"Diabetologia"},{"issue":"S1","key":"10.1002\/14651858.CD003177.pub3-BIB0309|cit309","first-page":"99","article-title":"Peripheral sensory nerve function is independently associated with microvascular function, but neither are improved by n-3 fatty acids","volume":"32","author":"McCormick","year":"2015","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0310|cit310","first-page":"1","article-title":"Potential benefits of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease (NAFLD): a potential treatment for early NAFLD in metabolic syndrome and type 2 diabetes? Results from the WELCOME study","volume":"31","author":"Scorletti","year":"2014","journal-title":"Diabetic Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cct.2014.02.002","article-title":"Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected]","volume":"37","author":"Scorletti","year":"2014","journal-title":"Contemporary Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cct.2014.04.004","article-title":"Design and rationale of the WELCOME trial: a randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease","volume":"38","author":"Scorletti","year":"2014","journal-title":"Contemporary Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study","volume":"60","author":"Scorletti","year":"2014","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2015.07.036","article-title":"Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial","volume":"63","author":"Scorletti","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-160439","article-title":"Effects of DHA supplementation on hippocampal volume and cognitive function in older adults with mild cognitive impairment: a 12-month randomized, double-blind, placebo-controlled trial","volume":"55","author":"Zhang","year":"2016","journal-title":"Journal of Alzheimer's Disease"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0317|cit317","first-page":"32","article-title":"Effects of a diet including linseed oil on clinical and metabolic parameters in patients with type 2 diabetes mellitus","volume":"69","author":"Alekseeva","year":"2000","journal-title":"Voprosy Pitaniia"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0318|cit318","first-page":"1","article-title":"Utility of heavy food supplement in omega-3 fatty acids in the prevention of dementia, in relation to the basal nutritional level, in people of advanced age: randomized multicenter study","volume":"50","author":"Baleztena Gurrea","year":"2015","journal-title":"Revista Espa\u00f1ola de Geriatr\u00eda y Gerontolog\u00eda"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0319|cit319","first-page":"38","article-title":"Utility of a rich food supplement Omega-3 fatty acids in the prevention of dementia, in relation to baseline nutritional level, in people with advanced age: multicentre randomised study","volume":"9","author":"Bes-Rastrollo","year":"2015","journal-title":"Nutrici\u00f3n Cl\u00ednica en Medicina"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/ard.47.2.96","article-title":"Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study","volume":"47","author":"Belch","year":"1988","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"24","key":"10.1002\/14651858.CD003177.pub3-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199606133342401","article-title":"Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease","volume":"334","author":"Belluzzi","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0322|cit322","first-page":"2578","article-title":"One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation","volume":"24","author":"Berthoux","year":"1992","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0140-6736(65)92842-4","article-title":"Effect of linseed oil on platelet adhesiveness and bleeding time in patients with coronary heart disease","volume":"ii","author":"Borchgrevink","year":"1965","journal-title":"Lancet"},{"issue":"456","key":"10.1002\/14651858.CD003177.pub3-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(66)92474-3","article-title":"Absence of prophylactic effect of linolenic acid in patients with coronary heart disease","volume":"2","author":"Borchgrevink","year":"1966","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0325|cit325","first-page":"87","article-title":"Effect of N-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study","volume":"11","author":"Busnach","year":"1998","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0326|cit326","unstructured":"NCT02525198 The cognitive ageing nutrition and neurogenesis trial (CANN) clinicaltrials.gov\/ct2\/show\/NCT02525198"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0327|cit327","first-page":"157","article-title":"N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease","volume":"10","author":"Cappelli","year":"1997","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0328|cit328","unstructured":"ISRCTN10431469 Changes in brain function among individuals with a mild memory impairment (CARES) www.isrctn.com\/ISRCTN10431469"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0329|cit329","first-page":"368","article-title":"The effect of omega-3 fatty acids on restenosis after coronary angioplasty","volume":"11","author":"Cheng","year":"1990","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ndt\/5.4.241","article-title":"The effect of fish oil dietary supplement on the progression of mesangial IgA glomerulonephritis","volume":"5","author":"Cheng","year":"1990","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ki.1993.215","article-title":"Fish oil in lupus nephritis: clinical findings and methodological implications","volume":"44","author":"Clark","year":"1993","journal-title":"Kindney International"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0272-6386(12)70273-1","article-title":"Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis","volume":"23","author":"Clark","year":"1994","journal-title":"American Journal of Kidney Diseases"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD003177.pub3-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/07315724.2001.10719026","article-title":"Flaxseed in lupus nephritis: a two-year nonplacebo-controlled crossover study","volume":"20","author":"Clark","year":"2001","journal-title":"Journal of the American College of Nutrition"},{"issue":"1-2","key":"10.1002\/14651858.CD003177.pub3-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02919106","article-title":"Biochemical and clinical effects of an antioxidative supplementation of geriatric patients. A double blind study","volume":"20","author":"Clausen","year":"1989","journal-title":"Biological Trace Element Research"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000186022","article-title":"Fish oil to prevent intimal hyperplasia and access thrombosis","volume":"55","author":"Diskin","year":"1990","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199411033311804","article-title":"A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group","volume":"331","author":"Donadio","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0337|cit337","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1079\/BJN2001376","article-title":"Inter-pregnancy folate and iron status of women in an inner-city population","volume":"86","author":"Doyle","year":"2001","journal-title":"British Journal of Nutrition"},{"issue":"2-3","key":"10.1002\/14651858.CD003177.pub3-BIB0338|cit338","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000235421","article-title":"Effect of a fish oil diet on asthma: results of a 1-year double-blind study","volume":"95","author":"Dry","year":"1991","journal-title":"International Archives of Allergy and Applied Immunology"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3177\/jnsv.45.759","article-title":"Long-term effects of dietary alpha-linolenic acid from perilla oil on serum fatty acids composition and on the risk factors of coronary heart disease in Japanese elderly subjects","volume":"45","author":"Ezaki","year":"1999","journal-title":"Journal of Nutritional Science & Vitaminology"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000085248","article-title":"Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10","volume":"219","author":"Feher","year":"2005","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3945\/ajcn.112.041343","article-title":"Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish","volume":"96","author":"Browning","year":"2012","journal-title":"American Journal of Clinical Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S0007114513002985","article-title":"Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans","volume":"111","author":"Walker","year":"2014","journal-title":"British Journal of Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1017\/S0007114515002251","article-title":"Fatty acid profile of plasma NEFA does not reflect adipose tissue fatty acid profile","volume":"114","author":"Walker","year":"2015","journal-title":"British Journal of Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.3390\/nu7085285","article-title":"The pattern of fatty acids displaced by EPA and DHA following 12 months supplementation varies between blood cell and plasma fractions","volume":"7","author":"Walker","year":"2015","journal-title":"Nutrients"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0345|cit345","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.nut.2008.10.008","article-title":"Milk enriched with \"healthy fatty acids\" improves cardiovascular risk markers and nutritional status in human volunteers","volume":"25","author":"Fonolla","year":"2009","journal-title":"Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1567-5688(10)70266-X","article-title":"Daily intake of a dairy drink enriched with omega-3 (EPA+DHA) and oleic acid improves cardiovascular markers in healthy postmenopausal women","volume":"11","author":"Fonolla","year":"2010","journal-title":"Atherosclerosis Supplements"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0347|cit347","first-page":"86","article-title":"Daily intake of a low lactose dairy drink enriched with omega-3 (EPA+DHA), oleic acid and calcium improves nutritional and bone status in healthy postmenopausal women","volume":"6","author":"Fonolla","year":"2011","journal-title":"Clinical Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0348|cit348","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/07315724.2014","article-title":"Daily intake of milk enriched with n-3 fatty acids, oleic acid, and calcium improves metabolic and bone biomarkers in postmenopausal women","volume":"35","author":"Fonolla-Joya","year":"2016","journal-title":"Journal of the American College of Nutrition"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003177.pub3-BIB0349|cit349","first-page":"28","article-title":"Long-term effect of fish oil and olive oil on plasma lipids in patients with CHD","volume":"78","author":"Franzen","year":"1989","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0350|cit350","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/rheumatology\/ken024","article-title":"Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis","volume":"47","author":"Galarraga","year":"2008","journal-title":"Rheumatology"},{"issue":"1-2","key":"10.1002\/14651858.CD003177.pub3-BIB0351|cit351","first-page":"46","article-title":"Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance","volume":"69","author":"Gapparova","year":"2000","journal-title":"Voprosy Pitaniia"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0352|cit352","first-page":"151","article-title":"Influence of omega-3 fatty acids on the prostaglandin-metabolism in healthy volunteers and patients suffering from PVD","volume":"37","author":"Gazso","year":"1992","journal-title":"Agents and Actions. Supplements"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0353|cit353","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.1780370608","article-title":"Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study","volume":"37","author":"Geusens","year":"1994","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0354|cit354","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<403::AID-CNCR21>3.0.CO;2-1","article-title":"Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial","volume":"82","author":"Gogos","year":"1998","journal-title":"Cancer"},{"issue":"9213","key":"10.1002\/14651858.CD003177.pub3-BIB0355|cit355","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(00)02145-0","article-title":"Scotopic sensitivity in dyslexia and requirements for DHA supplementation","volume":"355","author":"Greatrex","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0356|cit356","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/cs0970269","article-title":"Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects","volume":"97","author":"Griffin","year":"1999","journal-title":"Clinical Science"},{"issue":"8384","key":"10.1002\/14651858.CD003177.pub3-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(84)92355-9","article-title":"Eicosapentaenoic acid and IgA nephropathy","volume":"1","author":"Hamazaki","year":"1984","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0358|cit358","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03009749609104066","article-title":"Nutritional status of Danish rheumatoid arthritis patients and effects of a diet adjusted in energy intake, fish-meal, and antioxidants","volume":"25","author":"Hansen","year":"1996","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0359|cit359","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/07315724.1991.10718148","article-title":"Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months","volume":"10","author":"Harris","year":"1991","journal-title":"Journal of the American College of Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0360|cit360","first-page":"S610","article-title":"Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function in elderly people with very mild dementia in Japan","volume":"1","author":"Hashimoto","year":"2011","journal-title":"Alzheimer's and Dementia"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0361|cit361","first-page":"193","article-title":"Beneficial effects of daily dietary omega-3 polyunsaturated fatty acid supplementation on age related cognitive decline in elderly Japanese with very mild dementia: a 2-year randomized,double-blind, placebo-controlled trial","volume":"1","author":"Hashimoto","year":"2012","journal-title":"Journal of Aging Research & Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/ggi.12691","article-title":"Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes","volume":"17","author":"Hashimoto","year":"2017","journal-title":"Geriatrics & Gerontology International"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0363|cit363","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/gut.33.7.922","article-title":"Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial","volume":"33","author":"Hawthorne","year":"1992","journal-title":"Gut"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0364|cit364","doi-asserted-by":"crossref","first-page":"A15530","DOI":"10.1161\/circ.132.suppl_3.15530","article-title":"Omega-3 fatty acids supplementation attenuates the progression of microalbuminuria in diabetics with coronary artery disease","volume":"132","author":"Lakshminarayan","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0365|cit365","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0272-6386(95)90445-X","article-title":"A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy","volume":"26","author":"Hogg","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0366|cit366","unstructured":"NCT01744275 High dose omega 3 fatty acids supplementation in patients with epilepsy: the HOPE-Epilepsy trial clinicaltrials.gov\/ct2\/show\/NCT01744275"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1007\/BF02637099","article-title":"N-3 fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa","volume":"31","author":"Huang","year":"1996","journal-title":"Lipids"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0368|cit368","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1167\/iovs.07-1420","article-title":"Oral supplementation of lutein\/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD","volume":"49","author":"Huang","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0369|cit369","unstructured":"ISRCTN38354847 A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate [EPA]) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy www.isrctn.com\/ISRCTN38354847"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0370|cit370","first-page":"323","article-title":"Serum enzymes in grade I hypertensive patients before and following a change in nutrition in relation to polyene acid and electrolyte content","volume":"45","author":"Junker","year":"1990","journal-title":"Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0371|cit371","first-page":"86","article-title":"Total lipid content in the blood after using fish oil in natural and emulsified forms","volume":"26","author":"Kachorovskii","year":"1977","journal-title":"Farmatsiia"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0372|cit372","first-page":"39","article-title":"Influence of perindopril, rosuvastatin, or omega-3 polyunsaturated fatty acids on efficacy of antirecurrence therapy with sotalol in patients with persistent atrial fibrillation","volume":"47","author":"Kanorskii","year":"2007","journal-title":"Kardiologiia"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0373|cit373","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13590849862276","article-title":"Plasma omega-3 fatty acids before and after nutritional therapy","volume":"8","author":"Karlsson","year":"1998","journal-title":"Journal of Nutritional & Environmental Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0374|cit374","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0167-5273(92)90059-C","article-title":"Fish oil supplements for prevention of restenosis after coronary angioplasty","volume":"35","author":"Kaul","year":"1992","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0375|cit375","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0008-6363(03)00395-X","article-title":"The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects","volume":"59","author":"Khan","year":"2003","journal-title":"Cardiovascular Research"},{"issue":"10","key":"10.1002\/14651858.CD003177.pub3-BIB0376|cit376","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1442-2042.2000.00211.x","article-title":"Effect of ethyl icosapentate on urinary calcium and oxalate excretion","volume":"7","author":"Konya","year":"2000","journal-title":"International Journal of Urology"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0377|cit377","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/art.1780380813","article-title":"Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates","volume":"38","author":"Kremer","year":"1995","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0378|cit378","first-page":"385","article-title":"Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis","volume":"10","author":"Kruger","year":"1998","journal-title":"Aging (Milano)"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0379|cit379","first-page":"521","article-title":"Eicosapentaenoic acid effect on hyperlipidemia in menopausal Japanese women. The Niigata Epadel Study Group","volume":"96","author":"Kurabayashi","year":"2000","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0380|cit380","first-page":"137","article-title":"Effects of Maxepa on non-steroidal anti-inflammatory drug useage in patients with mild rheumatoid arthritis","volume":"30","author":"Lau","year":"1991","journal-title":"British Journal of Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0381|cit381","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/32.11.982","article-title":"Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis: a double-blind placebo controlled study","volume":"32","author":"Lau","year":"1993","journal-title":"British Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0382|cit382","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ajcn\/62.1.68","article-title":"Incorporation of dietary n-3 fatty acids into the fatty acids of human adipose tissue and plasma lipid classes","volume":"62","author":"Leaf","year":"1995","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0383|cit383","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3129\/i10-028","article-title":"Effect of docosahexaenoic acid supplementation on the macular function of patients with Best vitelliform macular dystrophy: randomized clinical trial","volume":"45","author":"Lee","year":"2010","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0261-5614(98)80318-X","article-title":"Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease","volume":"17","author":"Leng","year":"1998","journal-title":"Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0385|cit385","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0952-3278(97)90137-X","article-title":"Randomised controlled trial of y-linolenic and eicosapentaenoic acid in peripheral vascular disease","volume":"57","author":"Leng","year":"1997","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0386|cit386","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2012.05.2093","article-title":"The Lipididiet study: rationale and study design","volume":"1","author":"Freund-Levi","year":"2012","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0387|cit387","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.neurobiolaging.2014.01.108","article-title":"A clinical trial investigating the effects of Souvenaid in prodromal Alzheimer's disease: progress and baseline characteristics of the Lipididiet study","volume":"35","author":"Soininen","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD003177.pub3-BIB0388|cit388","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jalz.2013.05.1381","article-title":"A randomized controlled trial investigating the effects of Souvenaid in prodromal Alzheimer's disease: baseline characteristics of the LipiDiDiet study","volume":"9","author":"Visser","year":"2013","journal-title":"Alzheimer's & Dementia"},{"issue":"10","key":"10.1002\/14651858.CD003177.pub3-BIB0389|cit389","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/BF02093614","article-title":"N-3 fatty acids only delay early relapse of ulcerative colitis in remission","volume":"41","author":"Loeschke","year":"1996","journal-title":"Digestive Diseases and Sciences"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0390|cit390","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamaophthalmol.2013.2851","article-title":"Macular xanthophylls and omega-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial","volume":"131","author":"Arnold","year":"2013","journal-title":"JAMA Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0391|cit391","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00417-013-2376-6","article-title":"Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study","volume":"251","author":"Dawczynski","year":"2013","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"8911","key":"10.1002\/14651858.CD003177.pub3-BIB0392|cit392","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/S0140-6736(94)92580-1","article-title":"Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. [Erratum appears in Lancet 1995 Mar 18;345(8951):738]","volume":"343","author":"Lorgeril","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0393|cit393","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.ejcn.1600374","article-title":"Control of bias in dietary trial to prevent coronary recurrences: the Lyon Diet Heart Study","volume":"51","author":"Lorgeril","year":"1997","journal-title":"European Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0394|cit394","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0735-1097(96)00280-X","article-title":"Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments","volume":"28","author":"Lorgeril","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD003177.pub3-BIB0395|cit395","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archinte.158.11.1181","article-title":"Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate","volume":"158","author":"Lorgeril","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0396|cit396","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"Lorgeril","year":"1999","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0397|cit397","first-page":"30","article-title":"Does a Mediterranean dietary pattern prolong survival?","volume":"16","author":"Lorgeril","year":"1999","journal-title":"Cardiology Review"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD003177.pub3-BIB0398|cit398","doi-asserted-by":"crossref","first-page":"1360S","DOI":"10.1093\/ajcn\/61.6.1360S","article-title":"Cretan Mediterranean diet for prevention of coronary heart disease","volume":"61","author":"Renaud","year":"1995","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0399|cit399","first-page":"846","article-title":"Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy","volume":"27","author":"Maachi","year":"1995","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0400|cit400","first-page":"336","article-title":"The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)","volume":"106","author":"Macsai","year":"2008","journal-title":"Transactions of the American Ophthalmological Society"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0401|cit401","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1749-6632.1990.tb17819.x","article-title":"A randomized trial of dietary intervention with essential fatty acids in patients with categorized cysts","volume":"586","author":"Mansel","year":"1990","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0402|cit402","first-page":"138","article-title":"A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis","volume":"9","author":"Mantzaris","year":"1996","journal-title":"Hellenic Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0403|cit403","first-page":"A228","article-title":"Does dietary fish oil maintain the remission of Crohn's disease: a study case control","volume":"100","author":"Mate","year":"1991","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0404|cit404","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1378\/chest.128.6.3817","article-title":"Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD","volume":"128","author":"Matsuyama","year":"2005","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0405|cit405","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1365-2036.2002.01286.x","article-title":"A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis","volume":"16","author":"Middleton","year":"2002","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0406|cit406","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12888-016-0900-z","article-title":"Prevention of depression through nutritional strategies in high-risk persons: rationale and design of the MooDFOOD prevention trial","volume":"16","author":"Roca","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0407|cit407","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s13063-017-2275-y","article-title":"A randomised, double-blind, placebo-controlled trial of minocycline and\/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol","volume":"18","author":"Qurashi","year":"2017","journal-title":"Trials"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0408|cit408","unstructured":"NCT01235533 Fish oil supplementation in late-life depression clinicaltrials.gov\/ct2\/show\/NCT01235533"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0409|cit409","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mad.2014.03.001","article-title":"Reprint of: a parallel randomized trial on the effect of a healthful diet on inflammageing and its consequences in European elderly people: design of the NU-AGE dietary intervention study","volume":"136","author":"Berendsen","year":"2014","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0410|cit410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mad.2013.12.001","article-title":"Combating inflammaging through a Mediterranean whole diet approach: the NU-AGE project's conceptual framework and design","volume":"136-137","author":"Santoro","year":"2014","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0411|cit411","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2318-14-74","article-title":"Effects of omega3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study","volume":"14","author":"Laake","year":"2014","journal-title":"BMC Geriatrics"},{"issue":"8","key":"10.1002\/14651858.CD003177.pub3-BIB0412|cit412","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneurol.2012.283","article-title":"Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Torkildsen","year":"2012","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0413|cit413","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/1056-8727(95)00081-X","article-title":"Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus","volume":"10","author":"Okuda","year":"1996","journal-title":"Journal of Diabetes and its Complications"},{"issue":"1-2","key":"10.1002\/14651858.CD003177.pub3-BIB0414|cit414","first-page":"326","article-title":"Rationale and design of the \"OLIVE\" study (comparison of an olive oil enriched to a low fat diet intervention study using vascular endpoints)","volume":"134","author":"Colquhoun","year":"1997","journal-title":"Atheroscerosis"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003177.pub3-BIB0415|cit415","first-page":"S24","article-title":"Comparison of an olive oil enriched diet to a low fat diet intervention study using vascular endpoints: assessed by repeat quantitative angiography (OLIVE study)","volume":"55","author":"Colquhoun","year":"1998","journal-title":"Australian Journal of Nutrition and Dietetics"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0416|cit416","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.CIR.42.5.935","article-title":"The Oslo diet-heart study. Eleven year report","volume":"42","author":"Leren","year":"1970","journal-title":"Circulation"},{"issue":"21","key":"10.1002\/14651858.CD003177.pub3-BIB0417|cit417","first-page":"658","article-title":"The effect of a cholesterol lowering diet in male survivors of myocardial infarction. (A controlled clinical trial)","volume":"77","author":"Leren","year":"1967","journal-title":"Nordisk Medicin"},{"issue":"Suppl","key":"10.1002\/14651858.CD003177.pub3-BIB0418|cit418","first-page":"1","article-title":"The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial","volume":"466","author":"Leren","year":"1966","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0419|cit419","first-page":"1012","article-title":"The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial","volume":"44","author":"Leren","year":"1968","journal-title":"Bulletin of the New York Academy of Medicine"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0420|cit420","first-page":"32","article-title":"Lipid peroxidation in patients with ischemic heart disease, hyperlipidemia and\/or hypertension while polyunsaturated omega-3 fatty acids of plant and animal origin were in their diet","volume":"4","author":"Pogozheva","year":"1997","journal-title":"Voprosy Pitaniia"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0421|cit421","first-page":"33","article-title":"The effect of an antiatherosclerotic diet including omega-3 polyunsaturated fatty acids of marine and plant origins on the indices of cellular and humoral immunity in patients with ischemic heart disease and a disordered carbohydrate tolerance","volume":"69","author":"Pogozheva","year":"2000","journal-title":"Voprosy Pitaniia"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0422|cit422","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jclinepi.2010.09.013","article-title":"Describing reporting guidelines for health research: a systematic review","volume":"64","author":"Moher","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0423|cit423","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1177\/147323000803600505","article-title":"Reduction in cerebral atrophy associated with ethyl-eicosapentaenoic acid treatment in patients with Huntington's disease","volume":"36","author":"Puri","year":"2008","journal-title":"Journal of International Medical Research"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0424|cit424","first-page":"1","article-title":"Effect of hilsa (Tenualosa ilisha) fish in hypercholesterolemic subjects","volume":"20","author":"Quazi","year":"1994","journal-title":"Bangladesh Medical Research Council Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0425|cit425","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.HYP.31.5.1130","article-title":"Seven-year incidence of hypertension in a cohort of middle-aged African Americans and whites","volume":"31","author":"He","year":"1998","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0426|cit426","first-page":"916A","article-title":"Coagulation parameters among healthy adults taking fish oil versus placebo","volume":"10","author":"Meilahn","year":"1990","journal-title":"Arteriosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0427|cit427","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004872-199402000-00014","article-title":"Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention","volume":"12","author":"Sacks","year":"1994","journal-title":"Journal of Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0428|cit428","first-page":"S23","article-title":"The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the trials of hypertension prevention","volume":"12","author":"Sacks","year":"1994","journal-title":"Journal of Hypertension. Supplement"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0429|cit429","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0749-3797(18)30721-9","article-title":"Recruitment for phase I of the Trials of Hypertension Prevention","volume":"9","author":"Satterfield","year":"1993","journal-title":"American Journal of Preventive Medicine"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0430|cit430","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.1992.03480090061028","article-title":"The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, phase I","volume":"267","author":"Trials of Hypertension Prevention Collaborative Research Group","year":"1992","journal-title":"JAMA"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD003177.pub3-BIB0431|cit431","doi-asserted-by":"crossref","first-page":"652S","DOI":"10.1093\/ajcn\/65.2.652S","article-title":"Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention","volume":"65","author":"Whelton","year":"1997","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0432|cit432","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/bmj.297.6657.1196","article-title":"Fish oil and plasma fibrinogen","volume":"297","author":"Saynor","year":"1988","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0433|cit433","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF02536136","article-title":"Changes in blood lipids and fibrinogen with a note on safety in a long term study on the effects of n-3 fatty acids in subjects receiving fish oil supplements and followed for seven years","volume":"27","author":"Saynor","year":"1992","journal-title":"Lipids"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0434|cit434","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00400104","article-title":"Plasma endothelin-1 immunoreactivity is increased following long-term dietary supplementation with omega-3 fatty acids in microalbuminuric IDDM patients","volume":"38","author":"Selvais","year":"1995","journal-title":"Diabetologia"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0435|cit435","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-8227(95)01056-J","article-title":"Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients","volume":"28","author":"Shimizu","year":"1995","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0436|cit436","first-page":"71","article-title":"Effect of low W-6\/W-3 fatty acid ratio Paleolithic style diet in patients with acute coronary syndromes: a randomized, single blind, controlled trial","volume":"4","author":"Singh","year":"2012","journal-title":"World Heart Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0437|cit437","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/bmj.304.6833.1015","article-title":"Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up","volume":"304","author":"Singh","year":"1992","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0438|cit438","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1007757724505","article-title":"Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival 4","volume":"11","author":"Singh","year":"1997","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0439|cit439","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1007757724505","article-title":"Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival 4","volume":"11","author":"Singh","year":"1997","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0440|cit440","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000073793","article-title":"Effects of an Indo-Mediterranean diet on the omega-6\/omega-3 ratio in patients at high risk of coronary artery disease: the Indian paradox","volume":"92","author":"Pella","year":"2003","journal-title":"World Review of Nutrition and Dietetics"},{"issue":"9344","key":"10.1002\/14651858.CD003177.pub3-BIB0441|cit441","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(02)11472-3","article-title":"Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial","volume":"360","author":"Singh","year":"2002","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD003177.pub3-BIB0442|cit442","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF00274540","article-title":"The effect of fish-oil on the remission of type 1 (insulin-dependent) diabetes in newly diagnosed patients","volume":"32","author":"Tariq","year":"1989","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0443|cit443","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.1007\/BF02562338","article-title":"Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases","volume":"34","author":"Terano","year":"1999","journal-title":"Lipids"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0444|cit444","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thrombosis & Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0445|cit445","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/diacare.20.1.26","article-title":"Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial","volume":"20","author":"Torjesen","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0446|cit446","doi-asserted-by":"crossref","first-page":"408180","DOI":"10.1155\/2015\/408180","article-title":"Enhanced oxidative stress and other potential biomarkers for retinopathy in type 2 diabetics: beneficial effects of the nutraceutic supplements","volume":"2015","author":"Roig-Revert","year":"2015","journal-title":"BioMed Research International"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0447|cit447","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archopht.121.9.1269","article-title":"Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa","volume":"121","author":"Wheaton","year":"2010","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD003177.pub3-BIB0448|cit448","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000052507","article-title":"Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers","volume":"39","author":"Yasui","year":"2001","journal-title":"European Urology"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0449|cit449","first-page":"62","article-title":"Changes in arterial pressure, serum lipids and thromboxane B2 after using a diet with various levels of eicosapentaenoic acid in patients with hypertension","volume":"65","author":"Zinger","year":"1987","journal-title":"Klinicheskaia Meditsina"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0450|cit450","unstructured":"ACTRN12614000732684 The Aboriginal cardiovascular omega-3 randomised controlled trial www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=366337"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0451|cit451","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00125-008-1179-5","article-title":"Atorvastatin in factorial with omega-3 EE90 risk reduction in diabetes (AFORRD): a randomised controlled trial","volume":"52","author":"Holman","year":"2009","journal-title":"Diabetologia"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0452|cit452","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2010.09.013","article-title":"Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial","volume":"213","author":"Neil","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0453|cit453","first-page":"A556","article-title":"ASCEND: design and baseline characteristics of a large randomised trial in diabetes","volume":"61","author":"Bowman","year":"2012","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0454|cit454","unstructured":"NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00135226"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0455|cit455","unstructured":"ACTRN12610000594022 Fish oil as adjunct therapy for periodontitis www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=335470"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0456|cit456","unstructured":"ACTRN12610000032055 The Beyond Ageing Project: A selective prevention trial using novel pharmacotherapies in an older age cohort at risk for depression Query! https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=308413"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0457|cit457","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13063-015-0762-6","article-title":"The Beyond Ageing Project Phase 2: a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial","volume":"16","author":"Cockayne","year":"2015","journal-title":"Trials"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0458|cit458","unstructured":"Chandrakala G Arpana G Rao PV Long-term effects of a reduced fat diet intervention in pre-diabetes 70th Scientific Sessions of the American Diabetes Association; 25-29 June 2010; Orlando (FL) 2010 195 PO"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0459|cit459","first-page":"A190","article-title":"Low-fat (< 20%) diets prevent type 2 diabetes mellitus","volume":"61","author":"Chandrakala","year":"2012","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0460|cit460","unstructured":"ChiCTR-TRC-12002014 Influence of different source of n-3 fatty acid on plasma lipid in moderately hypercholesterolemia subject and the valid dosage www.chictr.org.cn\/hvshowproject.aspx?id=2374"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0461|cit461","unstructured":"Do-Health DO-HEALTH trial web site do-health.eu\/wordpress"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0462|cit462","unstructured":"NCT01745263 DO-HEALTH \/ Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial (DO-HEALTH) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01745263"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0463|cit463","unstructured":"NCT02128763 Dry eye assessment and management study (DREAM) clinicaltrials.gov\/ct2\/show\/NCT02128763"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0464|cit464","unstructured":"NCT02676466 The ENRGISE pilot study (ENRGISE) clinicaltrials.gov\/ct2\/show\/NCT02676466"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0465|cit465","unstructured":"ACTRN12613000034730 Intervention of testosterone & fish oil as a possible strategy for the prevention of Alzheimer's disease www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=363372"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0466|cit466","unstructured":"NCT01513252 Long-term effects of interventional strategies to prevent cognitive decline in elderly (MAPT-PLUS) clinicaltrials.gov\/ct2\/show\/NCT01513252"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0467|cit467","unstructured":"NCT00010868 Omega-3 fatty acids in bipolar disorder clinicaltrials.gov\/ct2\/show\/NCT00010868"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0468|cit468","unstructured":"NCT00309439 ALA and prostate cancer clinicaltrials.gov\/ct2\/show\/NCT00309439"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0469|cit469","unstructured":"NCT00410020 Arrhythmia prevention with an alpha-linolenic enriched diet clinicaltrials.gov\/ct2\/show\/NCT00410020"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0470|cit470","unstructured":"NCT01784042 Dietary energy restriction and omega-3 fatty acids on mammary tissue clinicaltrials.gov\/ct2\/show\/NCT01784042"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0471|cit471","unstructured":"NCT02211560 Investigating a phosphatidylserine based dietary approach for the management of mild cognitive impairment clinicaltrials.gov\/ct2\/show\/NCT02211560"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0472|cit472","unstructured":"NCT02295059 Omega 3 fatty acids and ERPR(-)HER2(+\/-) breast cancer prevention clinicaltrials.gov\/ct2\/show\/NCT02295059"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0473|cit473","unstructured":"NCT02719327 Brain amyloid and vascular effects of eicosapentaenoic acid (BRAVE-EPA) clinicaltrials.gov\/ct2\/show\/NCT02719327"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0474|cit474","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2318-14-74","article-title":"Effects of omega 3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study","volume":"14","author":"Laake","year":"2014","journal-title":"BMC Geriatrics"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0475|cit475","doi-asserted-by":"crossref","first-page":"4945720","DOI":"10.1155\/2016\/4945720","article-title":"Serum fatty acids, traditional risk factors, and comorbidity as related to myocardial injury in an elderly population with acute myocardial infarction","volume":"2016","author":"Laake","year":"2016","journal-title":"Journal of Lipids"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0476|cit476","unstructured":"NCT01841944 Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction (OMEMI) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01841944"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0477|cit477","unstructured":"NCT01492361 A study of AMR101 to evaluate its ability to reduce cardiovascular events in high risk patients with hypertriglyceridemia and on statin. The primary objective is to evaluate the effect of 4 g\/day AMR101 for preventing the occurrence of a first major cardiovascular event (REDUCE-IT) clinicaltrials.gov\/ct2\/show\/NCT01492361"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0478|cit478","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1745-6215-14-237","article-title":"A randomized controlled trial of eicosapentaenoic acid and\/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial","volume":"14","author":"Hull","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0479|cit479","unstructured":"NCT01953705 n-3 PUFA for Vascular Cognitive Aging https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01953705"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0480|cit480","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jalz.2015.06.847","article-title":"Omega 3 fatty acids for the prevention of vascular cognitive aging: methods and rationale for a phase II trial","volume":"11","author":"Shinto","year":"2015","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0481|cit481","unstructured":"EudraCT 2014-001069-28 A long-term outcomes study to assess statin residual risk reduction with EpaNova in high cardiovascular risk patients with hypertriglyceridemia (STRENGTH) www.clinicaltrialsregister.eu\/ctr-search\/search?query=2014-001069-28"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0482|cit482","unstructured":"NCT01047449 Improving the results of heart bypass surgery using new approaches to surgery and medication (SUPERIORSVG) clinicaltrials.gov\/ct2\/show\/NCT01047449"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0483|cit483","unstructured":"UMIN000012825 Effect of polyunsaturated fatty acids on vascular healing process in hyper-cholesterolemic patients with acute coronary syndrome upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000014981"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0484|cit484","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cct.2015.12.022","article-title":"Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)","volume":"47","author":"Bassuk","year":"2016","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0485|cit485","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cct.2016.01.003","article-title":"Lung VITAL: rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and\/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults","volume":"47","author":"Gold","year":"2016","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0486|cit486","first-page":"D44 COPD","article-title":"Baseline chronic obstructive pulmonary disease in the lung vitamin D and omega-3 trial","volume":"189","author":"Gold","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0487|cit487","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jalz.2015.06.843","article-title":"Cognitive substudy of the vitamin d and omega-3 trial (vital-cog): design of a large randomized trial of omega-3 and vitamin d supplements in relation to cognitive change","volume":"1","author":"Kang","year":"2015","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0488|cit488","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cct.2015.01.007","article-title":"VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and\/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL)","volume":"41","author":"LeBoff","year":"2015","journal-title":"Contemporary Clinical Trials"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0489|cit489","first-page":"1215","article-title":"Vitamin D and cancer and cardiovascular disease: ready for prime time?","volume":"17","author":"Manson","year":"2010","journal-title":"Menopause"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0491|cit490","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3949\/ccjm.77gr.10004","article-title":"Vitamin D and the heart: why we need large-scale clinical trials","volume":"77","author":"Manson","year":"2010","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0490|cit491","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease","volume":"33","author":"Manson","year":"2012","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0492|cit492","unstructured":"NCT01169259 Vitamin D and Omega-3 Trial (VITAL) (VITAL) https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT01169259"},{"issue":"Pt B","key":"10.1002\/14651858.CD003177.pub3-BIB0493|cit493","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jsbmb.2015.04.006","article-title":"Update on the Vitamin D and OmegA-3 trial (VITAL)","volume":"155","author":"Pradhan","year":"2016","journal-title":"Journal of Steroid Biochemistry & Molecular Biology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0494|cit494","first-page":"CRD42017079211","article-title":"Polyunsaturated fatty acids for musculoskeletal health and functional status in older adults","volume":"www.crd.york.ac","author":"Abdelhamid","year":"2017","journal-title":"PROSPERO"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0495|cit495","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012345.pub2","article-title":"Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease","author":"Abdelhamid","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0496|cit496","unstructured":"American Heart Association Fish and Omega-3 Fatty Acids www.heart.org\/HEARTORG\/HealthyLiving\/HealthyEating\/HealthyDietGoals\/Fish-and-Omega-3-Fatty-Acids_UCM_303248_Article.jsp#.WhfuRzenzIU"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0497|cit497","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0498|cit498","doi-asserted-by":"crossref","unstructured":"Balk EM Adam GP Langberg V Halladay C Chung M Lin L Omega-3 fatty acids and cardiovascular disease: an updated systematic review Rockville (MD): Agency for Healthcare Research and Quality; 2016. Evidence report\/technology assessment no. 223. AHRQ Publication No. 16-E002-EF. www.effectivehealthcare.ahrq.gov\/reports\/final.cfm 10.23970\/AHRQEPCERTA223","DOI":"10.23970\/AHRQEPCERTA223"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0499|cit499","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0025-6196(12)61879-5","article-title":"Marine fish oils: role in prevention of coronary artery disease","volume":"62","author":"Ballard-Barbash","year":"1987","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0500|cit500","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.0954-6820.1972.tb04782.x","article-title":"Plasma lipids and lipoproteins in Greenlandic west coast eskimos","volume":"192","author":"Bang","year":"1972","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0501|cit501","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.0954-6820.1976.tb08198.x","article-title":"The composition of food consumed by Greenland Eskimos","volume":"200","author":"Bang","year":"1976","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0502|cit502","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/sim.4780140406","article-title":"A random-effects regression model for meta-analysis","volume":"14","author":"Berkley","year":"1995","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0503|cit503","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1742-1241.2003.tb10490.x","article-title":"Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications","volume":"57","author":"Bhatnagar","year":"2003","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0504|cit504","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bmj.331.7511.266","article-title":"Expression of concern","volume":"331","author":"BMJ","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0505|cit505","unstructured":"British Nutrition Foundation N-3 fatty acids and health London: British Nutrition Foundation; 1999. Briefing paper"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0506|cit506","first-page":"CRD42017064110","article-title":"Dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus","volume":"www.crd.york.ac","author":"Brown","year":"2017","journal-title":"PROSPERO"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0507|cit507","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/ije\/dyn157","article-title":"Fish, human health and marine ecosystem health: policies in collision","volume":"38","author":"Brunner","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0508|cit508","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000422327","article-title":"Fish and ischaemic heart disease","volume":"72","author":"Burr","year":"1993","journal-title":"World Review of Nutrition and Dietetics"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0509|cit509","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1079\/PHN2004620","article-title":"The UK Women's Cohort Study: comparison of vegetarians, fish-eaters and meat-eaters","volume":"7","author":"Cade","year":"2007","journal-title":"Public Health Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0510|cit510","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.metabol.2003.09.007","article-title":"An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia","volume":"53","author":"Calabresi","year":"2004","journal-title":"Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD003177.pub3-BIB0511|cit511","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003833.pub4","article-title":"Omega-3 fatty acids for intermittent claudication","author":"Campbell","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0512|cit512","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MOL.0b013e3283616364","article-title":"Omega-3 fatty acids: mechanisms underlying \"protective effects\" in atherosclerosis","volume":"24","author":"Chang","year":"2013","journal-title":"Current Opinion in Lipidology"},{"issue":"7881","key":"10.1002\/14651858.CD003177.pub3-BIB0513|cit513","doi-asserted-by":"crossref","first-page":"e6698","DOI":"10.1136\/bmj.e6698","article-title":"Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis","volume":"345","author":"Chowdhury","year":"2012","journal-title":"BMJ"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003177.pub3-BIB0514|cit514","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1017\/S0007114512001596","article-title":"Long chain omega-3 fatty acids and cardiovascular disease: a systematic review","volume":"107","author":"Delgado-Lista","year":"2012","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0515|cit515","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"Special Issue","key":"10.1002\/14651858.CD003177.pub3-BIB0516|cit516","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/S0140-6736(13)61299-4","article-title":"Seafood omega-3 intake and risk of coronary heart disease death: an updated meta-analysis with implications for attributable burden","volume":"381","author":"Engell","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0517|cit517","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2261-14-70","article-title":"The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis","volume":"14","author":"Enns","year":"2014","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0518|cit518","unstructured":"Food Standards Agency UK Dioxins and PCBs in the UK diet: 1997 Total diet study samples Food Surveillance Information Sheet. Number 4\/00; 2000"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0519|cit519","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00041433-200402000-00006","article-title":"Antiarrhythmic effects of n-3 fatty acids: evidence from human studies","volume":"15","author":"Geelen","year":"2004","journal-title":"Current Opinion in Lipidology"},{"issue":"7454","key":"10.1002\/14651858.CD003177.pub3-BIB0520|cit520","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0521|cit521","unstructured":"McMaster University (developed by Evidence Prime, Inc) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0522|cit522","first-page":"CRD42017056092","article-title":"Dietary polyunsaturated fat for prevention and treatment of depression and anxiety","volume":"www.crd.york.ac","author":"Hanson","year":"2017","journal-title":"PROSPERO"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0523|cit523","first-page":"CRD42017056109","article-title":"Effects of supplementary dietary polyunsaturated fat on cancer incidence","volume":"www.crd.york.ac","author":"Hanson","year":"2017","journal-title":"PROSPERO"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0524|cit524","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006199-199111000-00007","article-title":"Randomisation by cluster","volume":"40","author":"Hauck","year":"1991","journal-title":"Nursing Research"},{"issue":"2","key":"10.1002\/14651858.CD003177.pub3-BIB0525|cit525","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cjca.2012.03.019","article-title":"Efficacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: a meta-analysis","volume":"29","author":"He","year":"2013","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0526|cit526","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0527|cit527","unstructured":"Higgins JP Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0528|cit528","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011737","article-title":"Reduction in saturated fat intake for cardiovascular disease","author":"Hooper","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0529|cit529","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011094.pub3","article-title":"Omega-6 fats for the prevention and treatment of cardiovascular disease","author":"Hooper","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9483","key":"10.1002\/14651858.CD003177.pub3-BIB0530|cit530","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0140-6736(05)67006-7","article-title":"Expression of concern: Indo-Mediterranean Diet Heart Study","volume":"366","author":"Horton","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0531|cit531","unstructured":"Joint FAO\/WHO Expert Committee on Food Additives Summary of the fifty-seventh meeting of JEFCA, 2001 http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/42578\/WHO_TRS_909.pdf?sequence=1"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0532|cit532","first-page":"CRD42017019049","article-title":"Dietary polyunsaturated fat for prevention and treatment of neurocognitive disorders","volume":"www.crd.york.ac","author":"Jimoh","year":"2017","journal-title":"PROSPERO"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0533|cit533","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hrtlng.2013.03.006","article-title":"Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials","volume":"42","author":"Khoueiry","year":"2013","journal-title":"Heart & Lung"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0534|cit534","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCOUTCOMES.112.966168","article-title":"Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis","volume":"5","author":"Kotwal","year":"2012","journal-title":"Circulation. Cardiovascular Quality & Outcomes"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0535|cit535","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega 3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD003177.pub3-BIB0536|cit536","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2012.262","article-title":"Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"172","author":"Kwak","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003177.pub3-BIB0537|cit537","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10654-012-9748-9","article-title":"Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis","volume":"27","author":"Larsson","year":"2012","journal-title":"European Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0538|cit538","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0539|cit539","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/ajcn\/69.5.872","article-title":"Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men","volume":"69","author":"Li","year":"1999","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0540|cit540","volume-title":"Dioxins: Chemical Analysis, Exposure and Risk Assessment","author":"Liem","year":"1997"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0541|cit541","unstructured":"MAFF UK Concentrations of metals and other elements in marine fish and shellfish Food Surveillance Information Sheet no.151; 1998"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0542|cit542","doi-asserted-by":"crossref","first-page":"e005033","DOI":"10.1161\/JAHA.112.005033","article-title":"N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials","volume":"2","author":"Mariani","year":"2013","journal-title":"Journal of the American Heart Association"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0543|cit543","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-8223(21)01118-4","article-title":"Omega-3 fatty acids: comparison of plant and seafood sources in human nutrition","volume":"91","author":"Nettleton","year":"1991","journal-title":"Journal of the American Dietetic Association"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0544|cit544","unstructured":"NICE Cardiovascular disease: risk assessment and reduction, including lipid modification Clinical guideline [CG181] www.nice.org.uk\/guidance\/cg181"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0545|cit545","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1475-2891-13-31","article-title":"U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008","volume":"13","author":"Papanikolaou","year":"2014","journal-title":"Nutrition Journal"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0546|cit546","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0022-2275(20)31576-5","article-title":"Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans","volume":"42","author":"Pawlosky","year":"2001","journal-title":"Journal of Lipid Research"},{"issue":"10","key":"10.1002\/14651858.CD003177.pub3-BIB0547|cit547","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/2012.jama.11374","article-title":"Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis","volume":"308","author":"Rizos","year":"2012","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0548|cit548","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovic","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"8934","key":"10.1002\/14651858.CD003177.pub3-BIB0549|cit549","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0550|cit550","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD003177.pub3-BIB0551|cit551","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1097\/MJT.0000000000000048","article-title":"Statin use mitigate the benefit of omega-3 fatty acids supplementation: a meta-regression of randomized trials","volume":"23","author":"Sethi","year":"2016","journal-title":"American Journal of Therapeutics"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0552|cit552","first-page":"16","article-title":"Meta-analysis regression","volume":"42","author":"Sharp","year":"1998","journal-title":"Stata Technical Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0553|cit553","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/07315724.1992.10718240","article-title":"Common purslane: a source of omega-3 fatty acids and antioxidants","volume":"11","author":"Simopoulos","year":"1992","journal-title":"Journal of the American College of Nutrition"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0554|cit554","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.plipres.2016.05.001","article-title":"Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults","volume":"63","author":"Stark","year":"2016","journal-title":"Progress in Lipid Research"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0555|cit555","first-page":"CRD42017068704","article-title":"Dietary polyunsaturated fat for prevention and treatment of inflammatory bowel disease","volume":"www.crd.york.ac","author":"Thorpe","year":"2017","journal-title":"PROSPERO"},{"issue":"1","key":"10.1002\/14651858.CD003177.pub3-BIB0556|cit556","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jclinepi.2011.07.006","article-title":"Concordance of randomized and nonrandomized studies was unrelated to translational patterns of two nutrient-disease associations","volume":"65","author":"Trikalinos","year":"2012","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0557|cit557","unstructured":"US Food Drug Administration What You Need to Know About Mercury in Fish and Shellfish www.fda.gov\/food\/foodborneillnesscontaminants\/metals\/ucm351781.htm (accessed May 2018)"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0558|cit558","unstructured":"U. S. Food Drug Administration Center for Food Safety and Applied Nutrition Office of Nutritional Products Labeling, and Dietary Supplements: Letter Regarding Dietary Supplement Health Claim for Omega-3 Fatty Acids and Coronary Heart Disease (Docket No. 91N-0103) www.fda.gov\/Food\/LabelingNutrition\/ucm073992.htm#cardio 2004"},{"issue":"7511","key":"10.1002\/14651858.CD003177.pub3-BIB0559|cit559","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/bmj.331.7511.281","article-title":"Suspected research fraud: difficulties of getting at the truth","volume":"331","author":"White","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0560|cit560","unstructured":"World Health Organization Cardiovascular Diseases (CVDs). Fact sheets; May 2017. www.who.int\/mediacentre\/factsheets\/fs317\/en"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0561|cit561","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0562|cit562","unstructured":"World Bank World Bank Country and Lending Groups - country classification datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0563|cit563","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/07853890802698834","article-title":"Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials","volume":"41","author":"Zhao","year":"2009","journal-title":"Annals of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003177.pub3-BIB0564|cit564","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.clinbiochem.2013.11.025","article-title":"The limited effect of omega-3 polyunsaturated fatty acids on cardiovascular risk in patients with impaired glucose metabolism: a meta-analysis","volume":"47","author":"Zheng","year":"2014","journal-title":"Clinical Biochemistry"},{"issue":"4","key":"10.1002\/14651858.CD003177.pub3-BIB0565|cit565","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003177.pub2","article-title":"Omega 3 fatty acids for prevention and treatment of cardiovascular disease","author":"Hooper","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003177.pub3-BIB0566|cit566","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/bmj.38755.366331.2F","article-title":"Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review","volume":"322","author":"Hooper","year":"2006","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003177.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003177.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T07:10:42Z","timestamp":1720422642000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003177.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":566,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003177.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,18]]}}}